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1. Summary  
Work Package III gathers indicators of the extent of misconduct and analyses how 
institutions respond to misconduct or deviance in science. Deliverable 3.5 focuses on the 
protocols and tools used by scholarly and scientific publishers to guard scientific integrity. 
Aside from an overview of the practices and aids in place at various publishing houses, 
the report contains a summary of the experiences collected through qualitative interviews 
with several editors and publishers, as well as an account of the tools themselves. 
 
2. Introduction 
Publishers1 seek to disseminate quality articles and books as part of their role in keeping 
the record of scientific and scholarly endeavours. This holds true whether a publishing 
house has a strong commercial drive or is non-profit oriented. Scientific publications 
serve not only as a means to record results or to foster field-oriented discussions, they are 
increasingly used as a means of evaluating scientists and organisations.2 These diverse 
functions can lead to conflicting interests and ethical dilemmas during a process that 
involves many actors: authors, lab technicians, funders, institutions, editors, reviewers, 
and publishers. 
 As actors heavily invested in the dissemination of the scientific record, publishers 
encounter a whole range of ethical issues, from how to deal with honest mistakes and grey 
cases to addressing instances of clear misconduct. As part of the empirical phase of 
PRINTEGER, the present deliverable looks into the manners in which publishers deal with 
scientific misconduct.  
 During the first section, the policies and tools used by publishers were explored. 
The aim of this overview was to compare the type of ethical issues that publishers cover 
on their public online presence. Although many of these issues might be covered in private 
correspondence between editors and authors, we felt an examination of the information 
publicly available to be more suitable. Firstly, as players in the dissemination of science, 
publishers benefit greatly by guarding the integrity of the record and thus their stance on 
ethical dilemmas should be publicly available.  Secondly, comparing this information 
would allow us to gain knowledge on the similarities and differences in the treatment on 
ethical issues. 
 In the second phase we sought to consider the specific experiences of editors and 
publishers concerning ethical dilemmas and the effectiveness of the various policies and 
tools in place. A total of nine editors and publishers from the humanities, social sciences, 
                                                          
1 In this study, the term publisher is used firstly as a general term for publishing houses, both commercial 
and non-for-profit. It is also used to refer to the role of publisher inside those organisations. When 
carrying interviews we have spoken to people in various roles insides these organisations, mainly editors 
and publishers. 
2 Fischer, BA, and MJ Zigmond. “Scientific Publishing.” In Encyclopedia of Applied Ethics, by Dan Callahan, 
Peter Singer, and Ruth Chadwick, 32–40, 2nd ed., n.d. 
https://ebookcentral.proquest.com/lib/leidenuniv/detail.action?docID=858617. 
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material sciences, pharmacology, data science, chemistry, and medicine were 
interviewed. The questions centred around the training received, the protocols and tools 
in place to deal with potential cases, the interpretation of misconduct, the subject of 
integrity with regards to transparency, and experiences with specific cases. 
 Lastly, the third phase of this report contains a description of the tools and 
protocols used to prevent misconduct that can happen before or during publication  and 
maintain the integrity of the record. These descriptions as well as the insights gained from 
the overview and interviews will serve as a basis for Deliverable V.5 on tool 
recommendations.  
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3. Policies and tools used in scholarly and scientific publishing 
Most players in the realm of scientific publishing share the common goal of presenting 
research findings in order to foster discussion within its corresponding community and 
to keep the record of the various disciplines. Understandably, the process to publish these 
findings varies depending on the size of the publisher, the type of publishing model, the 
scientific fields covered, and the languages in which the output is published. 
Seeking to cover these differences, the policies and tools of 12 publishing houses 
and organisations were reviewed: 
Publisher Type Size Publishing 
Brill commercial 
800 books p/y    
200 journals 
subscription 
OA options 
De Gruyter commercial 
700 journals    
1,300 new titles 
subscription 
OA options 
Elsevier commercial 
2,000 journals 
33,000+ books 
subscription 
OA options 
IOP Publishing non-for-profit 70 journals 
subscription 
OA options 
Oxford University Press (OUP) university 6,000 titles p/y 
subscription 
OA options 
Palgrave Macmillan commercial 
200 monographs   
57 journals 
subscription 
OA options 
Public Library of Science (PLOS) non-for-profit 7 journals OA 
Redalyc non-for-profit 1,200 journals OA repository 
Rockefeller University Press (RUP) non-for-profit 3 journals 
OA (after 6 
months) 
Springer commercial 
2,900 journals   
200,000 books 
subscription 
OA options 
Ubiquity Press commercial 
25 books                
53 journals 
OA 
Wiley commercial 
1,500 journals   
9,000+ books 
subscription 
OA options 
Table 1 Publishers reviewed3 
Amongst these we find large and small companies as well as commercial and non-
for-profit organisations that publish both journals and books on a wide range of scientific 
fields. The type of publishing mode was also considered and thus a few outlets focusing 
solely on Open Access are included. Finally, the possible differences between centre and 
periphery were taken in consideration by exploring Redalyc, a non-English based 
repository.4 
An objective of this work package was to explore the current integrity practices 
developed and used by publishers to ensure quality. Following this, the website of each 
                                                          
3 The data for this table was extracted from the publishers websites between January and March 2017. 
4 Redalyc (Red de Revistas Cientificas de America Latina y el Caribe, España y Portugal) is a platform 
which functions as a bibliographical database and digital library for scientific and scholarly production 
from Ibero-America (Spain, Portugal and Latin America).   
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organisation was thoroughly searched for policies that cover six common practices of 
misconduct for both journals and books: 
1. (Potential) conflicts of interest – are authors, editors and reviewers required to 
provide them? Are these type of conflicts defined or are there examples given? 
(indicated as CoI) 
2. Access to background data (for readers and reviewers) – is it required or 
recommended to give access to background data? Are there guidelines 
established to link to background data? (indicated as Acc data) 
3. Retraction of publications – are the policies for retracting articles clearly 
explained? Do they provide reasons for retractions. (indicated as Retract) 
4. Plagiarism and appropriation – are there policies in place dealing with 
plagiarism and appropriation? (indicated as Plag & app) 
5. Duplicate and redundant publication – are there policies in place concerning 
duplicate and redundant submissions? (indicated as Dupl & red) 
6. Compliance with ethical standards – are there policies requiring compliance 
that cover the rights of subjects—such as informed consent, privacy protection, 
and compliance with human clinical and animal testing ethical guidelines?  
(indicated as Stand) 
In addition to these practices, their use of IT tools as well as the visibility of 
these policies and infrastructures were considered.  
Initially, the review looked for differences between policies for book and 
journal authors, editors, and publishers. However, many publishers do not 
mention ethics specifically for book authors and some do not publish books at 
all, hence we have not included these data in the overview. The following table 
provides an overview of which policies are publicly available on the publishers’ 
websites: 
 Guidelines & policies 
IT Tools 
Publisher CoI Acc data Retract Plag & app Dupl & red Stand 
Brill 1/2 No 1/2 1/2 1/2 No No 
De Gruyter 1/2 No 1/2 1/2 1/2 No n/a 
Elsevier Yes Yes 1/2 Yes Yes Yes Yes 
IOP Yes 1/2 1/2 1/2 Yes Yes Yes 
OUP Yes No 1/2 1/2 1/2 Yes 1/2 
Palgrave Macmillan 1/2 1/2 Yes 1/2 1/2 No Yes 
PLOS Yes Yes 1/2 Yes 1/2 Yes Yes 
Redalyc No No No No No No No 
RUP Yes Yes 1/2 1/2 1/2 Yes Yes 
Springer Yes 1/2 Yes Yes Yes Yes Yes 
Ubiquity No Yes 1/2 1/2 No 1/2 Yes 
Wiley Yes No Yes 1/2 Yes Yes Yes 
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The legend 1/2 refers to issues that are partially covered. This is the case when a publisher 
refers to the issue but does not define it or give examples of it, or when the full information 
is scattered through several pages and requires a targeted search. For example, De 
Gruyter does not have any page on publishing ethics although a document on its policies 
was found in one of its journals after a targeted search. The explanation for the grading 
and some notes on each issue can be found below except for De Gruyter’s half points, as 
this has already been given above. 
 
3.1 Guidelines & Policies 
 
Conflicts of interest 
Publisher Conflict of Interest 
Brill 1/2 
De Gruyter 1/2 
Elsevier Yes 
IOP Yes 
OUP Yes 
Palgrave Macmillan 1/2 
PLOS Yes 
Redalyc No 
RUP Yes 
Springer Yes 
Ubiquity No 
Wiley Yes 
 
Most publishers mention in their policies that authors, editors, and reviewers must 
declare any potential conflict of interest. Of the publishers which were graded as half, Brill 
only mentions the issue for reviewers and editors but not for authors, and it does not 
explain to what CoI refers, while Palgrave Macmillan only mentions this issue for authors. 
Finally, PLOS goes further on this policy, as it requires the role of funders to also be 
declared.  
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Access to background data 
Publisher Access to  data 
Brill No 
De Gruyter No 
Elsevier Yes 
IOP 1/2 
OUP No 
Palgrave Macmillan 1/2 
PLOS Yes 
Redalyc No 
RUP Yes 
Springer 1/2 
Ubiquity Yes 
Wiley No 
 
Guarantying access to background data is not a standard requirement for the majority of 
publishers. Although many recommend such practice and some have a general research 
data policy, only a few offer storage options for datasets (except for research resources 
journals). For example, some IOP journals offer the opportunity to store supplementary 
data. However, for IOP, Palgrave Macmillan, and Springer there is no publisher-wide 
recommendation on background data. Authors are nevertheless expected to retain and 
record their data and results in an auditable manner for editors and reviewers. 
Ubiquity Press’s recommendation goes further by covering every object associated 
with the research such as software, datasets, and bioresources.  
 
Retraction of publications 
Publisher Retractions 
Brill 1/2 
De Gruyter 1/2 
Elsevier 1/2 
IOP 1/2 
OUP 1/2 
Palgrave Macmillan Yes 
PLOS 1/2 
Redalyc No 
RUP 1/2 
Springer Yes 
Ubiquity 1/2 
Wiley Yes 
 
The manner in which publishers communicate their policies on retractions varies widely. 
In general all publishers except the repository Redalyc mention the possibility of an 
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article being retracted when it does not abide by publishing and ethics standards. 
However, not all of them specify what can be considered a breach, probably owing to the 
assumption that most authors would know what it entails.    
 Brill, Elsevier, IOP, OUP, PLOS, RUP, and Ubiquity Press do not state clear policies 
for documenting and stating the reasons for retraction. Further, some publishers seem to 
use a standard sentence referring to “established publishing standards and ethics” for 
justifying retractions, which can obfuscate the difference between errors and intentional 
wrongdoing. This while the Committee on Publication Ethics (COPE) guidelines—to 
which most publishers subscribe—clearly states that notices of retraction should “state 
the reason(s) for retraction (to distinguish misconduct from honest error)”.5 
 
Plagiarism and appropriation 
Publisher 
Plagiarism & 
appropriation 
Brill 1/2 
De Gruyter 1/2 
Elsevier Yes 
IOP 1/2 
OUP 1/2 
Palgrave Macmillan 1/2 
PLOS Yes 
Redalyc No 
RUP 1/2 
Springer Yes 
Ubiquity 1/2 
Wiley 1/2 
 
Although almost all publishers cover the issue of plagiarism with a clear definition and 
examples6, few cover appropriation by reviewers. On the subject of plagiarism neither 
Brill nor Ubiquity mention it specifically, with the former stating that articles must be 
original and the latter that articles are screened by a similarity check. A small sample of 
Ubiquity’s journals (seven) showed that only one treats the subject of plagiarism. On the 
subject of appropriation, Wiley mentions it as a possible reviewer misconduct for editors 
to consider but it is not  specified on its reviewers guidelines.  
 
                                                          
5 Elizabeth Wager, Virginia Barbour, Steven Yentis, Sabine Kleinert, “Retractions: Guidance from the 
Committee on Publication Ethics (COPE),” COPE, 2 September 2009, accessed  27 June 2017, 
https://publicationethics.org/files/u661/Retractions_COPE_gline_final_3_Sept_09__2_.pdf. 
6 These definitions can be found under Appendix II. 
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Duplicate and redundant publication 
Publisher 
Duplication & 
redundancy 
Brill 1/2 
De Gruyter 1/2 
Elsevier Yes 
IOP Yes 
OUP 1/2 
Palgrave Macmillan 1/2 
PLOS 1/2 
Redalyc No 
RUP 1/2 
Springer Yes 
Ubiquity No 
Wiley Yes 
 
Similarly to the issues of plagiarism and appropriation, many publishers cover duplication 
and redundancy partially, often lacking clear definitions and the consequences of these 
types of breaches. The subject of duplicate publication is not covered specifically by the 
guidelines from Palgrave Macmillan, while redundant publications are not 
comprehensively covered by the online guidelines from Brill, OUP, PLOS, RUP. Finally it is 
worth noting that not all publishers use the same terminology. For example, Elsevier uses 
the term duplicate paraphrasing for redundant publication and OUP uses the term 
duplicate for redundant publication.  
 
Compliance of standards 
Publisher Standards 
Brill No 
De Gruyter No 
Elsevier Yes 
IOP Yes 
OUP Yes 
Palgrave Macmillan No 
PLOS Yes 
Redalyc No 
RUP Yes 
Springer Yes 
Ubiquity 1/2 
Wiley Yes 
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This category refers to policies covering a wide variety of standards, from the rights of 
human subjects, to compliance with ethical standards on clinical testing (human and 
animal), and the handling of hazardous substances. It can also refer to a positive advice 
from an institute’s ethical commission. Particular disciplines do not need to deal with 
some of these, for example animal testing standards for the humanities. However, 
informed consent and right to privacy are also relevant for the social sciences and some 
disciplines in the humanities.  
For the above overview, the guidelines were searched for policies referring to 
appropriate standards on the range of subjects covered by each publisher. Ubiquity Press 
does not cover it as a publisher, however one journal from the sample examined requires 
authors to have authorisation from their institutional committee for research involving 
humans. Finally, although De Gruyter cover very briefly the use of hazardous materials, it 
has no mention of any of the other standards hence the negative punctuation. 
 
3.2 Infrastructure 
IT tools 
Publisher IT Tools 
Brill No 
De Gruyter n/a 
Elsevier Yes 
IOP Yes 
OUP 1/2 
Palgrave Macmillan Yes 
PLOS Yes 
Redalyc No 
RUP Yes 
Springer Yes 
Ubiquity Yes 
Wiley Yes 
 
The majority of the publishers reviewed make use of at least one IT tool for scanning 
similarity in texts. Elsevier, IOP Publishing, Palgrave Macmillan, PLOS, Springer, Ubiquity 
Press, and Wiley make use of Crossref Similarity Check (powered by iThenticate). OUP 
uses a similarity check but this is not a standard for all the journals, however it specifies 
that every journal must be clear to its authors on how and when the check is run. It is not 
clear if De Gruyter makes use of a similarity check, they do not inform of this on their 
website nor on their publication ethics document. 
 
Visibility 
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The clear visibility of publishing ethic policies and regulations is sometimes lacking. This 
is particularly the case for large corporations, which have large and complicated websites. 
Concerning guidelines for book authors, most of the publishers with a dedicated section 
for these authors do not mention publishing ethics directly.  
At Elsevier and Wiley the information is scattered throughout several pages, which 
sometimes have slightly similar names but refer to different sections. The pages can be 
accessed through several paths and are not always interconnected. OUP and Palgrave 
Macmillan have its guidelines grouped in one page but it requires a thorough and 
complicated navigation to arrive to them. 
Brill, IOP Publishing, PLOS, Springer, and Ubiquity Press have an easy to find page 
where all its ethics guidelines are listed as well as links to more detailed information from 
other organisations such as the Committee on Publication Ethics (COPE). PLOS also 
provides quick access to each journal’s guidelines. RUP has some general policies under 
its Philosophy section but the ethical guidelines are to be found per journal.  
The ethical guidelines from De Gruyter were extremely difficult to find on the 
website. Their publication ethics guidelines were found as an article in a journal but only 
after a targeted online search. Finally, although they are a repository and not a publisher, 
Redalyc has no clear policies on publishing ethics. They only have a prominent declaration 
on Open Access. 
3.3 Summary 
The majority of the publishers reviewed have publishing ethics guidelines available on 
their website which cover several categories of scientific misconduct in publishing. Given 
that most are members of COPE (except for Brill, De Gruyter, and Redalyc) it is highly 
likely that these publishers cover several issues reviewed above through formal or 
informal communication with the authors, although this is not always clear from the 
public website.  
However, there seems to be a lack of consistency in how the issues are named and 
handled, with possible misconduct from reviewers not being widely covered. The 
visibility and accessibility of the policies is another issue worth highlighting, with De 
Gruyter and the repository Redalyc having a very poor coverage on the subject. 
It is worth noting that a few issues, such as plagiarism, are only very briefly or 
indirectly covered. This stance may suggest there is an assumption that authors will know 
what is appropriate behaviour or that publishers and editors have trust in scientists, 
scholars, and their editorial team.    
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4. Accounts from the work floor: experiences from editors and 
publishers 
After the initial exploration of what publishing organisations state as their guidelines, 
publishers and editors were interviewed in order to record their direct experiences with 
the policies on misconduct and the IT tools used to combat it. As with the publishing 
organisations, the first selection of journals intended to cover different disciplines, sizes 
of publishing organisations, publishing modes (commercial vs. OA), types of output 
(articles, books, reviews), and languages. A second criteria for this selection was 
experience with cases of (potential) misconduct, thus journals which had had cases of 
retractions or corrections, be it documented in the Web of Science, Retraction Watch, or 
other websites.   
From a total of 19 persons approached7, nine editors and publishers agreed to 
participate in an interview. The disciplines covered are: humanities, social sciences, 
material sciences, pharmacology, data science, chemistry, and medicine. The main focus 
of the interviews was to understand how editors and publishers from various disciplines 
perceive and handle misconduct. Beyond the regulations an organisation has, it was 
important to hear the kind of steps followed in practice when there is suspicion of 
misconduct. 
4.1 Questions and responses 
The subjects discussed during the interview can be divided into five large topics 
pertaining to the training received, the protocols and tools in place to deal with potential 
cases, the interpretation of misconduct, the subject of integrity with regards to 
transparency, and experiences with specific cases. It is important to note that although all 
the journals approached had at least one case of retraction or correction these cases did 
not always involved misconduct, nor were those interviewed necessarily the editors or 
publishers in charge when said case(s) had taken place.  
Training 
First we inquired about the type of training received, as this moment is when a publisher 
or journal defines the type of work expected to safeguard a certain level of quality. The 
level of training provided gives an indirect glance on how misconduct is perceived in 
different disciplines and publishers. For example, in certain disciplines there might not be 
formal training on potential misconduct, possibly as the cases tend to be rare and it is 
assumed everybody working on that field knows what misconduct is.  
The type of training received varies greatly depending on the size of the journal 
and the resources from the organisation behind it. In general, the most common method 
                                                          
7 From those 19,  five never replied, four declined, one accepted but could not participate due to other 
engagements, and two forwarded us to their publishers who had more experience in dealing with ethical 
issues. Aiming to cover differences between centre and periphery, two editors from Latin America were 
contacted however they never replied. From those who declined, one forwarded us to the journal’s 
guidelines and regulations while two implied they could not allocate time for an interview without some 
form of remuneration: a faculty member and an independent researcher. 
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is on-the-job training under supervision of senior colleagues, and for almost all cases 
except one it includes tutorials on the managing system for manuscripts. In five cases the 
training period is acknowledged as such and is complemented by presentations on 
different aspects of the publishing process, while for the rest the training is informal and 
part of the first months of work.   
The average duration of training is one month, with a couple of cases of a six-month 
to one-year period. There is a marked difference between internal editors and publishers 
working directly for the publishing house and editors-in-chief of small journals. In 
general, the in-house staff receives more specialised training and detailed presentations 
covering a variety of subjects. In a few cases the external editors receive webinars and 
other resources as presentations and handbooks; however this was not the case for four 
editors. This trend is also observed in the availability for continuous education as it is 
usually the internal staff which has more possibilities. Exceptions are update tutorials on 
the manuscript managing system and in a few cases, publishing ethics seminars offered 
by COPE. 
 Concerning ethics, the attention given to the subject during the coaching period 
shows different attitudes which could be partly explained by the incidence of cases and 
the discipline. The treatment of the subjects varies from specific presentations, to treating 
it through editorial board meetings or when cases come up, and cases in which there was 
no mention of ethical issues at all. Interestingly, the latter responses concerned editors 
from the humanities.  The rationale behind this seems to be the assumption that the 
concept of misconduct is clear and well-known, as well as considering serious breaches of 
ethics as the domain for the legal department.  
 Finally, awareness of COPE and its resources was queried. The majority of editors 
and publishers know of the committee although not all of them are familiar with their 
resources. There is no apparent relationship between the discipline covered and 
knowledge of the committee as the two interviewees who were unaware of it worked with 
subjects from material sciences and humanities. Those who know of and use the COPE 
resources find them extremely helpful for the subjects covered. 
Protocols and tools 
The second area covered by the interviews was related to the protocols and tools in place 
and how these are experienced. All journals and publishers have established a particular 
workflow for manuscript assessment, whether for invitation-only or open submissions. It 
is through this workflow that most potential cases are spotted.  
Concerning IT tools, the majority of publishers run the manuscripts automatically 
through a similarity check, with three cases (two journals and one publisher of the 
humanities) abstaining from doing so. In this particular note, the editors found their 
workflow more suitable for spotting possible issues for the kind of texts they handle, 
while the publisher mentioned they are beginning to run trials to see the effectiveness of 
it. A few publishing houses also run a duplicate-submission check to detect whether the 
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paper has not been submitted before to one of their journals. In general, for most journals 
and publishers where the similarity check is run automatically, an editor will review and 
evaluate the report on overlapping text. 
Besides the protocols and workflows covering text, a few publishers have specific 
workflows in place to assess the quality of images and whether they have been 
manipulated or not. This type of work is done by in-house editors and is not automated. 
On the subject of protocols for handling issues, the majority of those interviewed 
have formal protocols in place, often modelled after the COPE protocols and with links to 
the COPE guidelines and flowcharts. In a couple of journals and one publishing house in 
particular, editors rely rather on informal interaction and have a common sense approach 
such as discussing issues with the editorial board or the publisher in charge.  
When talking about the perceived efficiency of these protocols and tools, the 
editors and publishers who refrain from using similarity checks find their workflows 
sufficient for maintaining quality. They trust the work and knowledge of their editors, 
reviewers, and the scholarly community at large. Those who do run the similarity checks 
find these useful and helpful. Although the reports require manual evaluation by an editor, 
the scale of work taken off their hands is such that it would be impossible to assess a very 
large amount of submissions purely through human work.  Some editors perceived 
however some shortcomings on the similarity tools, specifically pertained to works in 
other languages than English and formally-unpublished texts, such as graduate students’ 
work. 
Finally the editors and publishers shared with us a few wishes for IT tools which 
could facilitate their work. Concerning similarity scanners, covering a wider range of 
sources including other languages would be quite useful. A tool which could run similarity 
checks for figures and images, as well as a tool that could automatically generate a report 
on possible image manipulation, would also be welcome. On the subject of data and 
statistics, tools that could identify manipulation and fabrication would aid the publishing 
endeavour, although the difference in disciplines might complicate a straightforward 
solution for all of these. 
Interpretation and responsibility of misconduct 
With regards to the interpretation of misconduct, the interviewees shared their views on 
what constitutes clear cases vs. grey ones. In general most editors and publishers see the 
deliberate misrepresentation of research and results as clear misconduct. As examples 
they mentioned plagiarism, data falsification and fabrication, statistical manipulation, and 
poor research practices such as lacking informed consent and not providing background 
data or replication information when it is a standard for the discipline involved. Stressing 
the intention, the editors see the clear cases as conscious choices to copy, falsify, 
obfuscate, or ignore standing protocols from their own disciplines. 
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 In contrast, the cases perceived as grey are those deemed less serious whether due 
to errors or ignorance. As examples, the interviewees mentioned authorship 
disagreements, data mismanagement, and certain forms of plagiarism. The cases of 
plagiarism deemed as grey involve self-plagiarism and ignorance on proper citation 
practices, differences in research cultures being a key point here. In general, there is the 
view that young researchers and students commit more errors, or errors that scientists 
and scholars commit less. With regards to copying images and figures, editors felt there is 
ignorance from the authors on the implications of this action. 
Most editors and publishers highlighted the difficulty of defining certain cases as 
plagiarism given that methodologies and certain descriptions are bound to be repeated 
across papers and journals. In a particular case the extent of the “damage” done was used 
as a measure: an editor mentioned a case of a reviewer adding citations to their own work 
as a grey area because it did not affect directly the work of others, despite the person 
being still employed by a faculty.      
When asked who is responsible for keeping misconduct out of manuscripts most 
interviewees lay it with the editors and publishers, although the authors are seen as 
bearing the ultimate responsibility. As one editor confided: a good scientist will carry out 
their research properly and therefore present a good paper. Another one added that a 
person with intent to be dishonest will seek to cheat not only the readers but also the 
editors and scientific community at large. Nevertheless many publishers feel that the fact 
that they are accountable for the copyright carries a large responsibility for them. Several 
confided that a good editor and publisher should spot issues with papers before 
publication. On this last point, a couple of editors highlighted that resources are an 
element of this equation: for-profit publishers have a larger responsibility than the non-
profit ones.  
Integrity and transparency 
The calls for more transparency and open data are recognised by editors and publishers 
as a partial response to cases of scientific publishing misconduct. In particular we 
inquired how their journals and publishing houses see Open Data and potential conflicts 
of interest. 
 Given the difference in disciplines covered, not all journals are involved with issues 
of Open Data. In specific the editors from the humanities feel this issue is not applicable 
to them: most of the texts handled in papers are already widely available nor are they a 
literary publisher that could guarantee proper publications of unknown literary works. 
For social sciences, the editors do not have specific regulations from within the journal 
and leave this to the requirements of the founding instance. 
 In contrast, those working on natural and applied sciences are more concerned 
with the issues of Open Data. For two journals, having Open Data sets is required except 
for a few cases, while the rest recommends the practice to their authors. Editors and 
publishers are discussing internally how to deal with storage, accessibility, and standards 
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issues while reviewing with colleagues from other publications and disciplines details 
such as sensitive issues and the development of policies. 
 Concerning potential conflicts of interest, the approaches also differ between the 
humanities and social sciences on the one hand, and the natural and applied sciences on 
the other hand. While the former leave these mostly to the authors and to the knowledge 
of the community of reviewers, the latter request authors to state potential conflicts of 
interest during the submission. In all journals there is no routine check on the veracity of 
said statements although several publishers see it as their responsibility to educate 
authors and reviewers of potential conflicts of interest.   
The interviewees see transparency measures such as Open Data as aids towards 
the improvement of science in general. Making data sets available will not only add to the 
scientific record but allow for a greater scrutiny of experiments and results, especially if 
failed trials and experiments are also documented.  
These measures can also aid in the prevention of misconduct although several 
editors raised concerns on how this objective will be implemented, stressing the necessity 
of having long-term accessibility and proper identification of data sets. Despite Open Data 
being seen as an anti-misconduct aid, one editor foresees possible future cases where 
scientists might fabricate whole data sets, albeit such a forgery would be difficult to do 
and hence to catch. Nevertheless the layer of accountability that an open data set adds will 
undoubtedly encourage scientists to be more careful with their data and results. 
Specific cases 
According to the interviewees, misconduct can be found in a very small percentage of 
publications. Impact however is big as it undermines the trust in science and potential 
cases require plenty of resources to investigate.  
Most cases of potential misconduct are identified through the similarity checks and 
the work of editors and reviewers, being thus handled during the pre-publication stage. A 
few of these cases will involve duplicate submissions that a reviewer has read for a 
different publication. When an issue is identified, the editors will contact the authors to 
solve this and only involve the publisher when the case gets more complicated. If there is 
no satisfactory solution and the quality of the work cannot be guaranteed, the paper is 
rejected.  
The majority of the post-publication cases are raised by readers concerning text or 
image plagiarism and in a few cases by scientists who contest authorship. Similarly to the 
pre-publication cases, if the issue cannot be solved between the editor and authors the 
publisher will be involved and in some cases the institution of the author will be notified 
requesting further aid in solving the mater. However, contacting the institution is not seen 
as a required step during this process as the conversation involves mainly the authors and 
editors. 
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There is only one case experienced by one of our interviewees where the 
investigation by the publisher found there was deliberate plagiarism. It affected several 
journals and took place during a large time span. The author involved never replied to the 
request for information by the various editors and so his articles were eventually 
withdrawn.  
A couple of cases handled by the interviewees merit special mention because they 
involved potential misconduct by reviewers and editors. In the first, already mentioned 
above, a reviewer added citations to his/her own work. The editors handling this case 
were junior editors and the department head was in transition; without clear protocols it 
was decided to not take further action unless the issue was raised by an author or another 
more senior editor. In the second, an editor that had been working on a book left to 
another publisher and published a very similar work at the new house but leaving some 
authors out. Given the complexities of challenging a non-published work, which is not 
exactly the same as challenging published work, no further action was taken. This 
highlights what another interviewee said when defining misconduct: it is what you can 
prove as misconduct. 
 Finally it is worth noting that cases of potential or established misconduct are 
thoroughly discussed at editorial boards and in some cases they result in improvements 
during the submission process. For example, in one case that resulted in a retraction the 
editors identified the need to request more detailed information during submission, to 
ensure all protocols were dully followed. 
4.2 Summary 
Misconduct in publishing is mostly seen as an extension of scientific misconduct. If 
researchers do their work properly and are guided by a good editor, the publications 
should be free of issues. At play thus are not only honesty and integrity but being rigorous 
both by the scientists and the editors. 
Publishers and editors recognise the integral part that their work plays in the 
scientific endeavour and take their role extremely seriously. They seek to guarantee a 
certain level of quality on the manuscripts accepted and do so by having an open 
relationship with their authors, other editors, and publishers. This is why most share the 
view that trust should be the fundament of scientific publishing rather than policing. 
 As much as IT tools come in handy for the publication process, the interviewees 
recognise how vital the human factor is. As part of their work with authors, editors have 
realised that many issues arise from lack of awareness. In their view, when authors, 
reviewers, editors, and publishers are knowledgeable on publishing ethics, the system 
works at its best. Therefore many publishers and editors see it as their role to educate the 
authors on certain issues such as proper citation practices for both of text and images.  
Concerning protocols, many guidelines are shared across publishers thanks to 
trade-wide discussions. COPE seems to be regarded as extremely useful although some 
were not aware of it or what it offers. Others find the guidelines and standards lacking on 
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certain issues such as data management but are confident that these issues will be more 
generally acknowledged with the call for more transparency on data. 
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5. Description of the tools 
Following the review and interviews, we find three types of tools widely used by editors 
and publishers to deal with possible misconduct: guidelines and regulations, similarity 
scanners, and protocols against data manipulation. 
5.1 Guidelines and regulations 
The guidelines and regulations as established by many publishers under the 
umbrella of COPE have proven extremely useful to editors and publishers. Through the 
interviews it became clear that this information provides guidance in most of the cases of 
suspected misconduct. These documents offer clear definitions and examples of different 
types of possible misconduct including flowcharts on what type of actions to take and 
which actors to contact.  
The COPE guidelines do not cover all possible cases thus many editors adapt them 
to their own needs or create new ones on subjects left out, for example on the integrity of 
datasets. Some international associations have also created their own guidelines based on 
discipline specific cases. In general, there seems to be very similar definitions throughout 
the different guidelines available online except for a few cases in which nomenclature is 
used differently, such as in the case of redundancy and duplication.   
The guidelines are not only useful for editors and publishers on being reactive but 
they work as a prevention tool in the sense of informing and educating researchers on the 
type of behaviour that is not acceptable. Concerning the language of the guidelines, most 
of them are in English as this is the language for most international publications. However 
some publishers have seen the need to better explain some types of common mistakes in 
other languages. These guides deal often with examples of plagiarism, proper citation, 
conflicts of interest, salami publishing, etc. As an editor confided, many authors are not 
native English speakers and giving more clear and detailed examples of misconduct in 
their own languages can be helpful.  
 Lastly, given that many cases of possible misconduct involve grey situations, the 
variety of examples offered and the possibility of discussing with colleagues from COPE 
or from the international associations aid editors in handling difficult cases. 
5.2 Similarity scanners 
The similarity scanners are extremely useful tools as some can check a document not only 
against papers published but also against grey literature and various texts on the web. 
The scanner will provide information concerned with any sort of text overlap such as 
references, bibliography, licenses, and quotations. Thus the reports produced still require 
an editor to check manually the results. 
 These scanners are extremely helpful for they have automatized a large part of the 
work. However the coverage seems to be lacking in some areas. Some editors mentioned 
that for some languages and subjects it is often better to make a Google search.  
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We ran a few tests with published and unpublished articles with mixed results in 
iThenticate. Some published articles hosted only in university or regional repositories 
have very little overlap while a Google search returns a link to the article tested. This was 
also the case for non-English articles. These results and the comments from editors will 
be taken into consideration or a next face of PRINTEGER on tool recommendation.  
5.3 Data and image manipulation 
The types of manipulation that can be found in an article are images, graphs, tables, and 
statistics. There are no completely automatized tools for tracking these type of 
misconduct, however many editors and publishers have developed processes for spotting 
these manipulations.  
The main shared problem with image and data manipulation relates to the various 
formats in which these two elements of scholarly publishing appear. In the case of data 
manipulations, it is difficult to detect errors, as the data often appear in some sort of 
spreadsheet format, which actually is a ‘second generation’ of the data produced in other 
platforms, such as in Python, MatLab, SAS, SQL, or measured in any other thinkable 
laboratory measurement tools. Dealing with manipulative actions is possible in 
spreadsheets, but this requires storage of data spreadsheets at publishers for review 
purposes, and not all publishers have such facilities implemented. If available, one can 
detect data manipulations by analysing the sheets by scrutinizing used formulas, and 
tracing back the graph values to raw data.  
When it comes to image manipulation, this relates to processes in which the power 
of the image is being strengthened by changing aspects such a clarity, and light/dark areas 
in an image. As with research data, and the issues with detecting manipulations, images 
come in many various formats. It is important to be able to track size and time-data 
stamps of images. Similar to research data, storage of images at the publisher is necessary 
for review purposes. Various software tools are being developed for usage in the 
publishing industry, but one single standard is not yet developed. 
As stated above, comparison of both tables, graphs and images as outcomes of the 
research process are complicated, as there is not, contrary to text analysis in plagiarism 
checks, a standard or baseline with which one can compare. Submission of more outcomes 
of the research process could be helpful, though not a definite solution (as manipulation 
can take place before submission. In that respect, this issue of detecting data and image 
manipulation can profit from the current development around open research data. This 
embodies a more open and transparent process of conducting research, on the outcomes 
as well as the choices made while conducting research. 
 
6. Conclusions and next steps 
As key actors in the dissemination of the scientific record editors and publishers deal with 
issues pertaining to scientific integrity, some of which are particular to the field of 
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publications. The similarity and difficulty of the cases of potential misconduct have led 
publishers to establish international guidelines through several organisations, most 
notably through the Committee on Publication Ethics (COPE). They have also sought to 
minimise the incidence of specific practices through the automation of part of the editorial 
processes, specifically for plagiarism. Next to these measures, editors convene with 
colleagues to discuss specific cases when these arise. 
 Remarkably, although the issues with potential misconduct in publishing are very 
similar and most publishers are members of trade-wide organisations, the way of 
presenting ethical policies on their public guidelines is not uniform in the subjects 
covered nor in nomenclature. In many cases, the ethical guidelines are difficult to find, 
and most do not cover all of the common potential cases. The lack of coverage on certain 
issues might suggest that knowledge of certain problems is assumed as commonplace, yet 
a more coordinated coverage of ethics guidelines could aid in creating awareness for 
authors across publishers and disciplines. 
 Despite the differences in (public) policies, editors and publishers share the view 
that publishing misconduct is an extension of scientific misconduct, which can result from 
a lack of rigour or plain lack of integrity. Many interviewees concurred that many 
potential cases are in fact due to unawareness from authors or honest mistakes. 
Therefore, they recognise that trust, open communication and human knowledge are a 
fundament of their trade. Nevertheless, many editors and publishers make use of IT tools 
such as similarity scanners to ease a few steps of the editorial workflow. 
 Concerning the tools widely used in scientific publishing, we found protocols and 
policies for complex issues as well as IT devices for text recognition. As much as the 
similarity scanners ease the workload of editors, the manuscript reports still require 
human judgement. The complexity of evaluating certain data such as images, tables, and 
statistics on a big scale; and the intricacy of potential cases make full automation for 
certain processes extremely difficult. This only highlights the importance of protocols that 
can aid the editorial workflow.  
 The findings of this empirical review will assist in Work Package V, concerned with 
policy advice and tool development. The experiences from editors and publishers on 
dealing with misconduct will be considered, as well as their needs without losing sight of 
the realities of publishing misconduct, its incidence and possible prevention. 
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Appendix I 
 
Below is a list of the pages on each publisher’s website that deal with publishing ethics. The 
pages were reviewed between December 2016 and May 2017. 
Brill 
 http://www.brill.com/resources/authors/publishing-journals-brill/publishing-ethics-
journals 
De Gruyter 
 https://www.degruyter.com/staticfiles/pdfs/140117_Publication_ethics_and_publicatio
n_malpractice_FINAL.pdf 
Elsevier 
 https://www.elsevier.com/about/company-information/policies 
 https://www.elsevier.com/about/our-business/policies/publishing-ethics 
 https://www.elsevier.com/authors/journal-authors/policies-and-ethics 
 https://www.elsevier.com/authors/book-authors/science-and-technology-book-
publishing/author-rights 
 https://www.elsevier.com/editors/perk 
 https://www.publishingcampus.elsevier.com/pages/63//ethics/Publishing-ethics.html 
IOP 
 http://authors.iop.org/ethicalpolicy 
 http://cms.iopscience.org/c3f83404-8d66-11e2-bd23-e50acbc9fd86/introduction.html 
 http://cms.iopscience.org/0e45b17e-c6a4-11e1-9609-4d5160a0f0b4/contents.html 
OUP 
 https://academic.oup.com/journals/pages/authors/ethics 
Palgrave Macmillan 
 http://www.palgrave.com/gp/journal-authors/ethics-policy/10052358 
PLOS 
 https://www.plos.org/editorial-publishing-policies 
Redalyc 
 no page on the subject 
RUP 
 http://www.rupress.org/content/our-philosophy 
 http://jcb.rupress.org/editorial-policies 
 http://jcb.rupress.org/about#reviewer-guidelines 
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 http://jem.rupress.org/editorial-policies 
 http://jem.rupress.org/about#reviewer-guidelines 
 http://jgp.rupress.org/editorial-policies 
 http://jgp.rupress.org/about#reviewer-guidelines 
Springer 
 https://www.springer.com/gp/authors-editors/journal-author/journal-author-
helpdesk/publishing-ethics/14214 
 http://resource-cms.springer.com/springer-
cms/rest/v1/content/19862/data/v1/Pubslishing+Ethics+Guide+for+Editors 
Ubiquity 
 http://www.ubiquitypress.com/site/research-integrity/ 
Wiley 
 https://authorservices.wiley.com/ethics-guidelines/index.html 
 https://authorservices.wiley.com/editors/ethical-guidelines/index.html 
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Appendix II 
 
Below is a list with publishers’ guidelines and policies publicly available on their websites 
concerning each of the points analysed on section 3 of this document. Only the general policies 
of each publisher have been included.8 
For some publishers, such as Elsevier, information on the subjects was found under different 
pages and addressed to different audiences, each statement is properly referenced at the 
footnotes. Further, in order to be a complete record as possible, the links mentioned in the 
statements have been included inside square brackets. 
 
(Potential) conflicts of interest  
Brill 
 Editors9 
Disclosure and conflicts of interest 
Material from submitted, unpublished manuscripts should be kept confidential and must 
not be used by others without the express written consent of the author. Editors should 
not consider reviewing manuscripts in which they have a conflict of interest. 
 Reviewers10 
Disclosure and conflict of interest 
Material from submitted, unpublished manuscripts should be kept confidential and must 
not be used by others without the express written consent of the author. Reviewers 
should not consider reviewing manuscripts in which they have a conflict of interest. 
De Gruyter 
 Editors-in-Chief11 
Disclosure and conflicts of interest 
Unpublished materials disclosed in a submitted manuscript must not be used in an 
Editor's own research without the explicit written consent of the author(s). 
 Peer reviewers12 
Disclosure and conflicts of interest 
Privileged information or ideas obtained through peer review must be kept confidential 
and not used for personal advantage. Reviewers should not consider evaluating 
manuscripts in which they have conflicts of interest resulting from competitive, 
                                                          
8 Two exceptions were made. Besides its general policies, PLOS has specific policies listed only under the 
policies of journals, however these policies apply to all their journals. RUP has no ethics policy under the 
general website, however their editorial policies are the same in all journals. This exception could not be 
applied to Ubiquity Press because they have 60 published journals and 7 hosted journals, each with its 
own guidelines and policies. As mentioned earlier, De Gruyter’s website has no page on ethical policies 
and thus a document found after a targeted search was used. 
9 “Publishing Ethics,” Brill, last accessed August 21, 2017, 
http://www.brill.com/resources/authors/publishing-journals-brill/publishing-ethics-journals 
10 Ibid 
11 “Publication Ethics and Publication Malpractice Statement,” De Gruyter, last accessed August 21, 2017, 
https://www.degruyter.com/view/j/ejnm.2013.5.issue-4/ejnm-2013-0037/ejnm-2013-0037.xml 
12 Ibid 
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collaborative, or other relationships or connections with any of the authors, companies, 
or institutions connected to the submission. 
 Authors13 
Disclosure and conflicts of interest  
All authors should disclose in their manuscript any financial or other substantive conflict 
of interest that might be construed to influence the results or their interpretation in the 
manuscript. All sources of financial support for the project should be disclosed. 
Elsevier 
 Editors14 
Declaration of Competing Interests.  
Any potential editorial conflicts of interest should be declared to the publisher in writing 
prior to the appointment of the editor, and then updated if and when new conflicts arise. 
The publisher may publish such declarations in the journal. 
The editor must not be involved in decisions about papers which s/he has written 
him/herself or have been written by family members or colleagues or which relate to 
products or services in which the editor has an interest. Further, any such submission 
must be subject to all of the journal’s usual procedures, peer review must be handled 
independently of the relevant author/editor and their research groups, and there must 
be a clear statement to this effect on any such paper that is published. 
The editor shall apply Elsevier’s policy relating to the disclosure of potential conflicts of 
interest by authors and reviewers, e.g. the ICMJE guidelines [ICMJE Uniform 
requirements for manuscripts submitted to biomedical journals http://www.icmje.org]. 
 Reviewers15 
Standards of Objectivity & Competing Interests.  
Reviews should be conducted objectively.  Reviewers should be aware of any personal 
bias they may have and take this into account when reviewing a paper. Personal 
criticism of the author is inappropriate. Referees should express their views clearly with 
supporting arguments. 
Reviewers should consult the Editor before agreeing to review a paper where they have 
potential conflicts of interest resulting from competitive, collaborative, or other 
relationships or connections with any of the authors, companies, or institutions 
connected to the papers. 
If a reviewer suggests that an author includes citations to the reviewer’s (or their 
associates’) work, this must be for genuine scientific reasons and not with the intention 
of increasing the reviewer’s citation count or enhancing the visibility of their work (or 
that of their associates). 
 Authors16 
Declaration of Competing Interests.  
WAME define conflict of interest as “a divergence between an individual’s private 
interests (competing interests) and his or her responsibilities to scientific and publishing 
activities, such that a reasonable observer might wonder if the individual’s behavior or 
                                                          
13 Ibid 
14 “Publishing Ethics,” Elsevier, last accessed August 23, 2017, https://www.elsevier.com/about/our-
business/policies/publishing-ethics 
15 Ibid 
16 Ibid 
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judgment was motivated by considerations of his or her competing interests”[World 
Association of Medical Editors (WAME) Best Practice 
http://www.wame.org/about/policy-statements]. All authors should disclose in their 
manuscript any financial and personal relationships with other people or organisations 
that could be viewed as inappropriately influencing (bias) their work. 
All sources of financial support for the conduct of the research and/or preparation of the 
article should be disclosed, as should the role of the sponsor(s), if any, in study design; in 
the collection, analysis and interpretation of data; in the writing of the report; and in the 
decision to submit the article for publication. If the funding source(s) had no such 
involvement then this should be stated. 
Examples of potential conflicts of interest which should be disclosed include 
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent 
applications/registrations, and grants or other funding. Potential conflicts of interest 
should be disclosed at the earliest possible stage. 
 Competing interests Quick Guide, Elsevier Publishing Campus17 
<https://www.publishingcampus.elsevier.com/websites/elsevier_publishingcampus/fil
es/Guides/2017%20ETHICS/2017_ETHICS_COI02.pdf > 
IOP Publishing 
 Authors18 
Conflicts of interest 
Articles should include a full list of the current institutional affiliations of all authors, 
both academic and corporate. We also encourage authors to provide ORCID identifiers 
for each named author on submission. 
All sources of financial support for the project should be disclosed in the article. 
All authors and co-authors are required to disclose any potential conflict of interest 
when submitting their article (e.g. employment, consulting fees, research contracts, stock 
ownership, patent licences, honoraria, advisory affiliations, etc.). If the article is 
subsequently accepted for publication, this information should be included in an 
acknowledgments section. 
It is difficult to specify the threshold at which a financial or other interest becomes 
significant. Two practical guidelines are: 
1. to declare any competing interests that could embarrass you were they to 
become publicly known after your work was published; 
2. to declare any information which, when revealed later, would make a reasonable 
reader feel misled or deceived. 
 Referees19 
Conflicts of interest  
Referees should contact the editorial office to declare any potential conflicts of interest 
in advance of refereeing an article (e.g. being a co-worker or collaborator with one of the 
authors, or being in a position which precludes giving an objective opinion of the work). 
Minor conflicts do not disqualify a referee from reporting on an article but will be taken 
                                                          
17 “Quick Guides,” Elsevier Publishing Campus, last accessed August 23, 2017, 
https://www.publishingcampus.elsevier.com/pages/63//ethics/Publishing-ethics.html 
18 “IOP ethical policy for journals,” IOP Publishing, last accessed August 23, 2017, 
http://ioppublishing.org/img/landingPages/guidelines-and-policies/ethical-policy.html 
19 Ibid 
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into account when considering the referees’ recommendations. Major conflicts of 
interest (especially relating to a financial commercial interest of over £5000/year) do 
disqualify a referee. Referees should act within the spirit of the Principles of Public Life 
[http://www.public-standards.gov.uk/about-us/what-we-do/the-seven-principles/]. 
Oxford University Press (OUP) 
 Authors20 
Conflict of interest exists when an author’s private interests might be seen as influencing 
the objectivity of research or experiment, to the point that a reasonable observer might 
wonder if the individual’s behaviour or judgement was motivated by considerations of 
his or her competing interests. It is the responsibility of a manuscript’s corresponding 
author to confirm if co-authors hold any conflict of interest.  The corresponding author 
may be required to co-ordinate completion of written forms from each co-author and 
submit these to the editor or journal administrator prior to acceptance.  The following 
should also be declared, either through the Acknowledgements section of the manuscript 
or at the point of submission: 
o All sources of research funding, including direct and indirect financial support, 
supply of equipment, or materials (including specialist statistical or writing 
assistance). 
o The role of the research funder(s) or sponsor(s), if any, in the research design, 
execution, analysis, interpretation, and reporting. 
o Any relevant financial and non-financial interests and relationships that might be 
considered likely to affect the interpretation of their findings or that editors, 
reviewers, or readers might reasonably wish to know. These might include, but 
are not limited to, patent or stock ownership, membership on a company’s board 
of directors, membership of an advisory board or committee for a company, 
consultancy for a company, or receipt of speaker’s fees from a company. 
When considering whether to declare a conflicting interest or connection we encourage 
authors to consider how they would answer the following question: Is there any 
arrangement that would embarrass you or any of your co-authors if it was to emerge 
after publication and you had not declared it? 
 Editors21 
OUP expects its journal editors to declare competing interests at the point of agreeing 
their position and update them annually. OUP’s standard editor agreement obliges the 
editor to declare any potential conflict of interest that might arise during the term of 
editorship prior to entry into any agreement or position. 
Editors are required to recuse themselves from individual manuscripts if they 
themselves have a potential conflict of interest and to avoid creating potential conflicts of 
interest through assignment of handling editors or peer reviewers. 
 Referees22 
We encourage editors and journal administrators to consider potential conflicts of 
interest when assigning reviewers. Some journals include wording in their invitation to 
review stating that acceptance of the invitation implies no financial or competing 
                                                          
20 “Publication Ethics,” Oxford University Press, last accessed August 23, 2017, 
https://academic.oup.com/journals/pages/authors/ethics 
21 Ibid 
22 Ibid 
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interest.  Where a reviewer declares potential conflict of interest the editor should select 
alternative reviewers. Failure to declare conflict of interest may result in removal of the 
reviewer from the journal database. 
Palgrave Macmillan 
 Authors23 
Openly disclose any conflict of interest - for example, if publication were to benefit a 
company or services in which the author(s) has a vested interest. 
Public Library of Science (PLOS) 
 Competing Interests24 
Authors, reviewers, and editors must declare potential competing interests, or interests 
that may be perceived as such, as they relate to the research. A competing interest may 
relate to a person or an entity and may be of a financial, non-financial, professional or 
personal nature. 
 Disclosure of Funding Sources25 
Research submitted to PLOS journals must be accompanied by a declaration of all 
financial support received to carry out the work. The role of the funder in the research 
must also be declared. 
Redalyc 
 Nothing on the subject 
Rockefeller University Press (RUP) 
 Conflict of interest26 
We take guidance from the National Institutes of Health and National Science Foundation 
in determining how to define a perceived conflict of interest. Reviewers and editors are 
asked to disclose any potential conflicts of interest prior to evaluating a manuscript. To 
avoid potential conflicts of interest, individuals should recuse themselves from 
evaluating a manuscript if any of the following points apply: 
o The author is at the same research organization or university 
o The author is a recent collaborator or trainee (less than five years), family 
member, or a close personal friend 
o The reviewer/editor, his/her immediate family, or a close professional associate 
has a financial or vested interest in the manuscript 
 
 
                                                          
23 “Ethics Policy ,” Palgrave Macmillan, last accessed August 23, 2017, 
http://www.palgrave.com/gp/journal-authors/ethics-policy/10052358 
24 “Editorial and Publishing Policies,” PLOS, last accessed August 23, 2017, 
https://www.plos.org/editorial-publishing-policies 
25 Ibid 
26 “Editorial Policies,” Rockefeller University Press, last accessed August 23, 2017, 
http://jgp.rupress.org/editorial-policies 
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Springer 
 Authors27 
Disclosure of potential conflicts of interest 
Authors must disclose all relationships or interests that could have direct or potential 
influence or impart bias on the work. Although an author may not feel there is any 
conflict, disclosure of relationships and interests provides a more complete and 
transparent process, leading to an accurate and objective assessment of the work. 
Awareness of a real or perceived conflicts of interest is a perspective to which the 
readers are entitled. This is not meant to imply that a financial relationship with an 
organization that sponsored the research or compensation received for consultancy 
work is inappropriate. 
Examples of potential conflicts of interests that are directly or indirectly related to the 
research may include but are not limited to the following: 
o Research grants from funding agencies (please give the research funder and the 
grant number) 
o Honoraria for speaking at symposia 
o Financial support for attending symposia 
o Financial support for educational programs 
o Employment or consultation 
o Support from a project sponsor 
o Position on advisory board or board of directors or other type of management 
relationships 
o Multiple affiliations 
o Financial relationships, for example equity ownership or investment interest 
o Intellectual property rights (e.g. patents, copyrights and royalties from such 
rights) 
o Holdings of spouse and/or children that may have financial interest in the work 
In addition, interests that go beyond financial interests and compensation (non-financial 
interests) that may be important to readers should be disclosed. These may include but 
are not limited to personal relationships or competing interests directly or indirectly tied 
to this research, or professional interests or personal beliefs that may influence your 
research. 
The corresponding author collects the conflict of interest disclosure forms from all 
authors. In author collaborations where formal agreements for representation allow it, it 
is sufficient for the corresponding author to sign the disclosure form on behalf of all 
authors. 
Examples of forms can be found here. 
o COI-all authors form [http://resource-cms.springer.com/springer-
cms/rest/v1/content/20116/data/v3/COI-all+authors+form] 
o COI-corresponding author form [http://resource-cms.springer.com/springer-
cms/rest/v1/content/20130/data/v3/COI-corresponding+author+form] 
o COI-ICMJE modified form [http://resource-cms.springer.com/springer-
cms/rest/v1/content/20132/data/v3/COI-ICMJE+modified+form] 
                                                          
27 “Publishing ethics,” Springer, last accessed August 23, 2017, https://www.springer.com/gp/authors-
editors/journal-author/journal-author-helpdesk/publishing-ethics/14214 
Promoting Integrity as an Integral Dimension 
of Excellence in Research 
D 3.5 Handling publishing misconduct | page 31 
 
o ICMJE form [http://resource-cms.springer.com/springer-
cms/rest/v1/content/20134/data/v5/ICMJE+form] 
Examples of disclosures 
The corresponding author will include a summary statement in the text of the 
manuscript in a separate section before the reference list, that reflects what is recorded 
in the potential conflict of interest disclosure form(s). 
o Funding, Funding: This study was funded by X (grant number X). 
o Conflict of Interest, Conflict of Interest: Author A has received research grants 
from Company A. Author B has received a speaker honorarium from Company X 
and owns stock in Company Y. Author C is a member of committee Z. 
o If no conflict exists, the authors should state, Conflict of Interest: The authors 
declare that they have no conflict of interest. 
 Editors28 
Undeclared conflict of interest (CoI) 
A  conflict  of  interest  is  a  situation  in  which  financial  or  other  personal  
considerations  from  authors  or  reviewers  have  the  potential  to  compromise  or  bias  
professional  judgment  and  objectivity.  Authors  and  reviewers  should declare  all  
conflicts  of  interest  relevant  to  the  work  under  consideration  (i.e.  relationships,  
both  financial  and  personal, that might interfere with the interpretation of the work) to 
avoid the potential for bias. 
Recommended action by COPE for Journal Editors: 
o What to do if a reviewer suspects undisclosed CoI in a submitted manuscript 
[http://publicationethics.org/files/u2/05A_CoI_Submitted.pdf] 
o What to do if a reader suspects undisclosed CoI in a published article 
[http://publicationethics.org/files/u2/05B_CoI_Published.pdf] 
Ubiquity Press 
 Nothing on the subject 
Wiley 
 Conflicts of Interest29 
Editors, authors, and peer reviewers should disclose  interests that might appear to 
affect their ability to present  or review work objectively. These might include relevant 
financial interests (for example, patent ownership, stock  ownership, consultancies, or 
speaker’s fees), or personal, political, or religious interests. 
The International Committee of Medical Journal Editors [http://www.icmje.org/] 
definition of conflicts of interest is as follows: 
“A conflict of interest exists when professional  judgment concerning a primary 
interest (such as  patients’ welfare or the validity of research) may  be influenced 
by a secondary interest (such as  financial gain). Perceptions of conflict of interest 
are  as important as actual conflicts of interest.”  
                                                          
28 “Publishing Ethics for journals,” Springer, last accessed August 23, 2017, http://resource-
cms.springer.com/springer-
cms/rest/v1/content/19862/data/v1/Pubslishing+Ethics+Guide+for+Editors 
29 “Editorial Standards and Processes,” Wiley, last accessed August 25, 2017, 
https://authorservices.wiley.com/ethics-guidelines/editorial-standards-and-processes.html 
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Strict policies preventing people with conflicts of interest  from publishing might 
encourage authors to conceal relevant interests, and might therefore be 
counterproductive.  
o Journal editors, board members, and staff who are  involved with decisions about 
publication should declare  their interests. Journals should consider publishing 
these on their website and updating them as required, as well as disclosing how 
conflicts of interest were managed for specific papers. 
o Editors should clearly explain what should be disclosed,  including the period 
that these statements should cover (for example, 3 years). Editors should ask 
authors to describe relevant funding, including the purpose of the funding (for 
example, travel grant and speaker’s fees), and to describe relevant patents, 
stocks, and shares that they own.  
o Editors should publish authors’ conflicts of interest whenever they are relevant, 
or a statement of their absence. If there is doubt editors should opt in favor of 
greater disclosure. 
o If authors state that there are no conflicts of interest, editors should publish a 
confirmation to this effect. 
o Editors should manage peer reviewers’ conflicts of interest. An invitation to 
review a manuscript should be accompanied by a request for the reviewer to 
reveal any potential conflicts of interest and a request for the peer reviewer to 
disqualify or recuse themselves when these are relevant. 
o When editors, members of editorial boards, and other editorial staff are 
presented with papers where their own interests may be perceived to impair 
their ability to make an unbiased editorial decision, they should withdraw from 
discussions, deputize decisions, or suggest that authors seek publication in a 
different journal. 
COPE has published flowcharts [http://publicationethics.org/resources/flowcharts] that 
illustrate a suitable process for investigations of suspected undisclosed conflicts of 
interest. 
Wiley uses a number of forms to capture conflicts of interest statements in online 
submission and peer review systems (for example,figure1 [not included in this 
appendix]). The International Committee of Medical Journal Editors has created a 
uniform disclosure form for conflicts of interest 
[http://www.icmje.org/coi_instructions.html]. 
 
Access to background data (for readers and reviewers)  
Brill 
 Nothing on the subject 
De Gruyter 
 Nothing on the subject 
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Elsevier 
 Authors30 
Data Access and Retention.  
Authors may be asked to provide the research data supporting their paper for editorial 
review and/or to comply with the open data requirements of the journal.  Authors 
should be prepared to provide public access to such data, if practicable, and should be 
prepared to retain such data for a reasonable number of years after publication. Authors 
may refer to their journal’s Guide for Authors for further details. 
 Research Data principles31 
o Research data should be made available free of charge to all researchers 
wherever possible and with minimal reuse restrictions. 
o Researchers should remain in control of how and when their research data is 
accessed and used, and should be recognised and valued for the investments they 
make in creating their research data and making it available. 
o Expectations and practices around research data vary between disciplines and 
discipline-specific requirements need to be taken into account. 
o Enabling effective reuse of research data is a shared aim and all stakeholders 
should work together to pursue this collectively, to find efficiencies and avoid 
duplication of effort. 
o Platforms, publications, tools and curation services can enhance research data by 
improving their discoverability, use, reuse, and citation. 
o Where others add value and/or incur significant cost in enhancing research data 
to enable its reuse, these contributions need to be recognized and valued. 
 Research Data Policy32 
o Encourage and support researchers to share research data where appropriate 
and at the earliest opportunity, for example by enhancing our submission 
processes to make this easier. 
o Standardize and align our author data guidelines where this is possible to make it 
easier for authors to understand how and where they can store and share their 
data, enabling optimal access and reuse. 
o  Make it easier for researchers to comply with data management requirements, 
for example by supporting data availability statements to enhance transparency. 
o Develop tools and services to support researchers to discover, use and reuse data 
to further their research, for example by encouraging and enabling two-way 
linking of relevant datasets and publications using permanent standard 
identifiers. 
o Ensure researchers can gain credit – and credit others - for sharing research data, 
by encouraging and supporting proper data citation practices. 
o  Work closely with the scientific community to establish data review practices to 
ensure that published research data is valid, properly documented and can be re-
used. 
                                                          
30 “Publishing Ethics,” Elsevier, last accessed August 23, 2017, https://www.elsevier.com/about/our-
business/policies/publishing-ethics 
31 “Research data,” Elsevier, last accessed August 23, 2017, https://www.elsevier.com/about/our-
business/policies/research-data 
32 Ibid 
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o Support the publication of research data as a separate, peer-reviewed output, to 
support reusability and provide additional ways for authors to gain credit for 
their work. 
o Support researchers, research institutions and funders by providing the 
structure, workflows and technology needed to manage data effectively and 
make researcher and institutional workflows more efficient, for example: 
 Providing Mendeley Data as a storage and preservation option for 
research data 
 Integrating HiveBench into the research workflow 
 Enabling the integration of these tools with other open standards and 
platforms 
o Continue to participate in industry initiatives and standards and policy bodies to 
support more effective discovery, use and reuse of research data, for example 
through our co-chairmanship of and participation in Research Data Alliance 
working groups, our engagement with the Scholix initiative, our membership of 
WDS and Codata, and through our partnerships with DANS, Force11 and others. 
IOP Publishing 
 Source materials33 
IOP Publishing does not require the raw data from an experiment to be submitted for 
publication, although some of our journals do offer the option to supply this data as 
supplementary information. However, we expect that all authors follow established best 
scientific practice and record (and retain) source material of experiments and research 
results, in an auditable manner that allows for scrutiny and verification by other 
scientists. Exceptions may be appropriate to preserve privacy or patent protection. 
There may also be specific instructions from your funding agency or university. 
Oxford University Press (OUP) 
 Nothing on the subject 
Palgrave Macmillan 
 Authors34 
Fully correspond and comply with the editor and publisher in any requests for source 
data, proof of authorship or originality in a timely manner, providing reasonable 
explanation for discrepancies or failures to disclose vital information. 
Public Library of Science (PLOS) 
 Data Availability35 
The data underlying the findings of research published in PLOS journals must be made 
publicly available. Rare exceptions may apply and must be agreed to with the Editor. 
                                                          
33 “IOP ethical policy for journals,” IOP Publishing, last accessed August 23, 2017, 
http://ioppublishing.org/img/landingPages/guidelines-and-policies/ethical-policy.html 
34 “Ethics Policy ,” Palgrave Macmillan, last accessed August 23, 2017, 
http://www.palgrave.com/gp/journal-authors/ethics-policy/10052358 
35 “Editorial and Publishing Policies,” PLOS, last accessed August 23, 2017, 
https://www.plos.org/editorial-publishing-policies 
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Data should be de-identified where appropriate (see Human Subjects and Animal 
Research). 
Redalyc 
 Nothing on the subject 
Rockefeller University Press (RUP) 
 Materials and data sharing36 
As a condition of publication, authors must make protocols and unique materials 
(including, but not limited to, cloned DNAs; antibodies; bacterial, animal, or plant cells; 
and viruses) described in our published articles freely available upon request by 
researchers, who may use them in their own laboratory only. All materials must be made 
available on request and without undue delay. If researchers are having difficulty 
obtaining materials from the authors of a published article, they should contact the 
journal’s editorial office. 
We encourage all authors to plan for the long-term storage and sharing of all original 
data underlying their manuscript. All datasets included in the manuscript must be 
available from the date of online publication, and the source code for all custom 
computational methods, apart from commercial software programs, must be made 
available either in a publicly available database or as supplemental materials hosted on 
the journal website. Numerous resources exist for data storage and sharing (see Data 
Deposition [http://jcb.rupress.org/data-deposition]), and authors should choose the 
most appropriate venue based on their data type and/or community standard. If no 
appropriate specific database exists, we encourage authors to deposit their data to an 
appropriate publicly available database. 
Springer 
o Upon request authors should be prepared to send relevant documentation or data in 
order to verify the validity of the results. This could be in the form of raw data, samples, 
records, etc. Sensitive information in the form of confidential or proprietary data is 
excluded.37 
Ubiquity Press 
 Research Data38 
All Ubiquity Press journals and books strongly encourage authors to make the research 
objects associated with their publications openly available. This includes research data, 
software, bioresources and methodologies. This means that peer reviewers are able to 
better assess the foundations of claims made, and the research community and wider 
public are able to similarly validate authors’ work, and are more easily able to extend 
and build upon it. 
                                                          
36 “Editorial Policies,” Rockefeller University Press, last accessed August 23, 2017, 
http://jgp.rupress.org/editorial-policies 
37 “Publishing ethics,” Springer, last accessed August 23, 2017, https://www.springer.com/gp/authors-
editors/journal-author/journal-author-helpdesk/publishing-ethics/14214 
38 “Research Integrity,” Ubiquity Press, last accessed August 25, 2017, 
https://www.ubiquitypress.com/site/research-integrity/ 
Promoting Integrity as an Integral Dimension 
of Excellence in Research 
D 3.5 Handling publishing misconduct | page 36 
 
All journals and books can be integrated with their own repository on the Dataverse 
Network [http://thedata.org/] as standard, and additional integration with subject-
specific repositories such as Dryad [http://datadryad.org/] is implemented on request. 
Authors also have the option of submitting data or software metapapers to any of our 
journals, or to a specifically themed metajournal 
[http://www.ubiquitypress.com/site/publish#metajournals]. This makes the associated 
resource more easily citable, and provides an additional incentive for the author to make 
it available. 
Wiley 
 Nothing on the subject 
 
Retraction of publications  
Brill 
 Authors39 
Errors in published work 
Authors who discover a major error in their own published work, are required to notify 
the publisher or editor and assist with withdrawal or correction of the manuscript. 
De Gruyter 
 In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism 
the publisher, in close collaboration with the Editors-in-Chief, will take all appropriate 
measures to clarify the situation and to amend the article in question. This includes the 
prompt publication of an erratum or, in the most severe cases, the complete retraction of 
the affected work.40 
Elsevier 
 Article retraction41 
Infringements of professional ethical codes, such as multiple submission, bogus claims of 
authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will 
be used to correct errors in submission or publication. 
The retraction of an article by its authors or the editor under the advice of members of 
the scholarly community has long been an occasional feature of the learned world. 
Standards for dealing with retractions have been developed by a number of library and 
scholarly bodies, and this best practice is adopted for article retraction by Elsevier: 
o A retraction note titled “Retraction: [article title]” signed by the authors and/or 
the editor is published in the paginated part of a subsequent issue of the journal 
and listed in the contents list. 
                                                          
39 “Publishing Ethics,” Brill, last accessed August 21, 2017, 
http://www.brill.com/resources/authors/publishing-journals-brill/publishing-ethics-journals 
40 “Publication Ethics and Publication Malpractice Statement,” De Gruyter, last accessed August 21, 2017, 
https://www.degruyter.com/view/j/ejnm.2013.5.issue-4/ejnm-2013-0037/ejnm-2013-0037.xml 
41 “Article withdrawal,” Elsevier, last accessed August 23, 2017, https://www.elsevier.com/about/our-
business/policies/article-withdrawal 
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o In the electronic version, a link is made to the original article. 
o The online article is preceded by a screen containing the retraction note. It is to 
this screen that the link resolves; the reader can then proceed to the article itself. 
o The original article is retained unchanged save for a watermark on the .pdf 
indicating on each page that it is “retracted.” 
o The HTML version of the document is removed. 
 Article removal: legal limitations42 
In an extremely limited number of cases, it may be necessary to remove an article from 
the online database. This will only occur where the article is clearly defamatory, or 
infringes others’ legal rights, or where the article is, or we have good reason to expect it 
will be, the subject of a court order, or where the article, if acted upon, might pose a 
serious health risk. In these circumstances, while the metadata (Title and Authors) will 
be retained, the text will be replaced with a screen indicating the article has been 
removed for legal reasons. 
 Article replacement43 
In cases where the article, if acted upon, might pose a serious health risk, the authors of 
the original article may wish to retract the flawed original and replace it with a corrected 
version. In these circumstances the procedures for retraction will be followed with the 
difference that the database retraction notice will publish a link to the corrected re-
published article and a history of the document. 
IOP Publishing 
 If an error occurs44 
It is, of course, recognised that errors will occur from time to time. When an error is 
discovered in published or submitted work, the mistake should be admitted and a 
corrigendum, erratum or retraction should be published. Corrections should be 
approved by all authors of the original article unless there is a particular reason why this 
is not possible. In these cases any dissent among the authors should be noted in the 
published correction. 
 Handling cases of misconduct45 
IOP is not able to actively police the policies and conditions of publication. Our 
relationship with our authors is based on trust and we publish submitted material in 
good faith. We believe that employers have the prime responsibility for ensuring their 
researchers’ good conduct and for the provision of ethical training and leadership. 
 However, it is our responsibility to maintain the integrity of the scientific record as far 
as possible. If a possible breach of this ethical policy, or similar misconduct affecting 
article(s) in our journals, is brought to our attention, we will ask the authors to respond. 
Whilst journals do not have the resources or legal legitimacy to fully investigate all 
allegations of scientific misconduct, we will seek advice from an article’s referees and/or 
the journal's Editorial Board. 
If there is then evidence that trust has been significantly compromised by an author’s or 
referee’s actions, we will attempt to redress the matter by: 
                                                          
42 Ibid 
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44 “IOP ethical policy for journals,” IOP Publishing, last accessed August 23, 2017, 
http://ioppublishing.org/img/landingPages/guidelines-and-policies/ethical-policy.html 
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1. if necessary, contacting editors of any other journals involved; 
2. publishing appropriate corrections in the printed and online journal (which may 
include retractions); 
3. refusing to consider an author’s future work, for a given period; 
4. in rare instances, communications to employers or funding agencies. 
In handling corrections to the published record, we follow the STM Guideline for the 
Preservation of the Objective Record of Science (2006) [http://www.stm-
assoc.org/2008_03_01_Preservation_of_the_Objective_Record_of_Science.doc]. 
IOP Publishing is a member of COPE, and adheres to the COPE Guidelines regarding 
misconduct and retractions. 
IOP reserves the right not to work with authors who are abusive to our staff, referees or 
editors. 
Oxford University Press (OUP) 
 Article submission46 
OUP takes every effort to ensure that editors, peer reviewers, and journal administrators 
treat all submissions respectfully, in confidence, and in accordance with COPE ethical 
guidelines. OUP expects that all individuals submitting manuscripts to OUP-published 
journals abide by established publishing standards and ethics. In proven cases of 
misconduct, the action taken will vary by journal and by context, but could result in one 
or more of the following: 
o Retraction of published work. 
o Publication of a correction or statement of concern. 
o Refusal of future submission. 
o Notification of misconduct sent to an author’s local institution, superior, and/or 
ethics committee. 
Palgrave Macmillan 
 Authors47 
Co-operate fully with the publication of errata and with the retraction of articles found to 
be unethical, misleading or damaging. 
 Editors48 
Be ready and prepared to publish corrections, corrigenda, errata when necessary, as well 
as retract articles that (the editor and Palgrave Macmillan) deem unethical, misleading 
or damaging. 
 What happens if ethical misconduct is detected?49 
(…) If ethical misconduct is discovered in content that has already been published, we 
may publish a statement of concern whilst the work is investigated. If we deem it 
necessary, the paper may be retracted with a statement of explanation. Other 
                                                          
46 “Publication Ethics,” Oxford University Press, last accessed August 23, 2017, 
https://academic.oup.com/journals/pages/authors/ethics 
47 “Ethics Policy ,” Palgrave Macmillan, last accessed August 23, 2017, 
http://www.palgrave.com/gp/journal-authors/ethics-policy/10052358 
48 Ibid 
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consequences may include a submissions ban for any or all authors, and contacting the 
relevant institution(s). 
Public Library of Science (PLOS) 
 In cases of suspected or alleged misconduct, we will follow the COPE flowcharts and may 
also seek advice at the COPE forum. If we find conclusive evidence of misconduct we will 
take steps to correct the scientific record, which may include issuing a correction or 
retraction.50 
Redalyc 
 Nothing on the subject 
Rockefeller University Press (RUP) 
 We investigate all instances of alleged scientific misconduct identified in our published 
papers (including, but not limited to, plagiarism, inappropriate data processing, and 
duplicate publication). Depending on the outcome of our investigation, we may publish a 
correction, ask authors to retract their paper, or publish an editorial statement of 
concern. 
In instances where we are considering revoking acceptance, retracting a published 
article, or issuing an editorial statement of concern, we will contact the corresponding 
author’s institution during the course of our investigation. As Committee on Publication 
Ethics (COPE) members, we abide by COPE guidelines in managing investigations of 
possible misconduct [http://publicationethics.org/resources/guidelines-new/sharing-
information-among-editors-chief-regarding-possible-misconduct].51 
Springer 
 Authors52 
If there is a suspicion of misconduct, the journal will carry out an investigation following 
the COPE guidelines.  If, after investigation, the allegation seems to raise valid concerns, 
the accused author will be contacted and given an opportunity to address the issue. If 
misconduct has been established beyond reasonable doubt, this may result in the Editor-
in-Chief’s implementation of the following measures, including, but not limited to: 
o If the article is still under consideration, it may be rejected and returned to the 
author. 
o If the article has already been published online, depending on the nature and 
severity of the infraction, either an erratum will be placed with the article or in 
severe cases retraction of the article will occur. The reason must be given in the 
published erratum or retraction note. Please note that retraction means that the 
paper is maintained on the platform, watermarked “retracted” and explanation 
for the retraction is provided in a note linked to the watermarked article. 
                                                          
50 “Ethical Publishing Practice,” PLOS, last accessed August 23, 2017, 
http://journals.plos.org/plosntds/s/ethical-publishing-practice 
51 “Editorial Policies,” Rockefeller University Press, last accessed August 23, 2017, 
http://jgp.rupress.org/editorial-policies 
52 “Publishing ethics,” Springer, last accessed August 23, 2017, https://www.springer.com/gp/authors-
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o The author’s institution may be informed. 
 Editors53 
How to correct the literature? 
In  some  cases  it  might  be  necessary  to  correct  the  literature  in  order  to  maintain  
the  integrity  of  the  research  literature. The COPE Retraction Guidelines 
[http://publicationethics.org/files/retraction%20guidelines.pdf] describe exactly when 
a nd which option should be used . 
Summary:  
o Erratum – Journal Editors  should consider issuing an erratum if: 
- a small portion of an otherwise reliable publication proves to be 
misleading (especially because of honest error) 
- the author/contributor list is incorrect  
o Retraction Note – Journal Editors should consider retracting a publication if: 
- there is clear evidence that the findings are unreliable, either as a result 
of misconduct or honest error  
- the findings have previously been published elsewhere without proper 
cross 
- referencing, permission  or justification  
- it constitutes plagiarism 
- it reports unethical research 
The text for retraction notes can be submitted/written by the author(s), Journal editor, 
Society or jointly. 
Expression of Concern – Journal  Editors  should consider issuing an expression of 
concern if: 
o there is inconclusive evidence of research or publication misconduct by the 
authors  
o there is evidence that the findings are unreliable but the authors’ institution will 
not investigate the  case 
o it is believed that an investigation into alleged misconduct related to the 
publication either has not  been, or would not be, fair and impartial or conclusive 
o an investigation is under way but a judgment will not be available for a 
considerable time 
Note! In all cases, please contact your Springer Publishing Editor first. 
Ubiquity Press 
 Nothing on the subject under general policies. 
Wiley 
 Retractions and Expressions of Concern54 
Wiley has published general advice on publishing retractions 
[http://authorservices.wiley.com/bauthor/faqs.asp#policy]and answers to frequently 
asked questions.  All Retraction statements published by Wiley are reviewed and 
                                                          
53 “Publishing Ethics for journals,” Springer, last accessed August 23, 2017, http://resource-
cms.springer.com/springer-
cms/rest/v1/content/19862/data/v1/Pubslishing+Ethics+Guide+for+Editors 
54 “Editorial Standards and Processes,” Wiley, last accessed August 25, 2017, 
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approved by Wiley lawyers.  
COPE has also published guidelines for retracting articles 
[http://publicationethics.org/files/retraction%20guidelines.pdf]. 
Retractions should be published when errors could affect the interpretation of data or 
information, or if work is proven to be fraudulent, or in other cases of serious ethical 
misconduct (for example, duplicate or redundant publication, failure of all authors to 
agree to publication, or plagiarism).  
Expressions of concern may be published if editors have well-founded concerns or 
suspicions and feel that readers should be made aware of potentially misleading 
information. Editors should do so with caution: an expression of concern carries the 
same risks to a researcher’s reputation as a retraction, and it is often preferable to wait 
to publish a retraction when a definitive judgment has been made by an independent 
investigation.  
 Withdrawal of Articles55 
Withdrawal or removal of articles is strongly discouraged. This policy is standard 
industry practice as described by the International Association of Scientific, Technical 
and Medical Publishers Guidelines on Preserving the Record of Science 
[http://www.stm-assoc.org/2006_04_19_Preserving_the_Record_of_Science.doc]. 
The practice of removal, deletion, or obscuring of an article or part of an article should be 
limited to circumstances such as: 
o Legal infringements, defamation, or other legal limitations; or 
o False or inaccurate data, especially those that if acted upon could pose a serious 
health risk.  
Even in these circumstances, a retraction statement must still be published to ensure 
that bibliographic information about the removed article is retained for the scientific 
record, and an explanation must be given about the circumstances of removal or 
withdrawal.  
Readers are also directed to the sections in this article which discuss Retractions and 
Expressions of Concern. 
 How to publish Retractions and Expressions of Concern56 
Guidelines on retracting articles, written by COPE, can be downloaded from their 
website [http://publicationethics.org/resources/guidelines].Similar to a Correction or 
an Erratum, the title of a Retraction or Expression of Concern should include the words 
“Retraction” or “Expression of Concern” as well as information to identify the article that 
it refers to. It should be published on a numbered page (print and electronic) and should 
be listed in the journal’s  table of contents. It should cite the original article and link 
electronically with the original electronic publication wherever possible. It should enable 
the reader to identify and understand why the article is being retracted, or should 
explain the editor’s concerns about the contents of the article. It should be in a form that 
enables indexing and abstracting services to identify and link to original publications. 
Finally, it should be free to access. 
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Plagiarism and appropriation 
Brill 
 Authors57 
Plagiarism 
Plagiarism is unethical. Authors are required to only submit their original manuscripts. 
In case material – in whatever form – of others is used, it must be appropriately cited or 
quoted. 
Source acknowledgement 
Proper acknowledgment of the work of others must always be given. Authors should cite 
publications that have influenced the content of their work. Information obtained 
privately, as in conversation, correspondence, or discussion with third parties, must not 
be used or reported without explicit, written permission from the original source. 
 Reviewers58 
Source acknowledgement 
Reviewers should identify relevant published work that has not been cited by the 
authors. Any statement that an observation, derivation, or argument had been previously 
reported should be accompanied by the relevant citation. A reviewer should also call to 
the editor's attention any substantial similarity or overlap between the manuscript 
under consideration and any other published work of which they have personal 
knowledge. 
De Gruyter 
 Peer reviewers59 
Acknowledgement of sources 
Reviewers should identify relevant published work that has not been cited by the 
authors. Any statement that an observation, derivation, or argument had been previously 
reported should be accompanied by the relevant citation. A reviewer should also call to 
the Editor's attention any substantial similarity or overlap between the manuscript 
under consideration and any other published data of which they have personal 
knowledge. 
 Authors60 
Originality and Plagiarism 
The authors should ensure that they have written entirely original works, and if the 
authors have used the work and/or words of others that this has been appropriately 
cited or quoted. 
Acknowledgement of sources 
Proper acknowledgment of the work of others must always be given. Authors should also 
cite publications that have been influential in determining the nature of the reported 
work. 
                                                          
57 “Publishing Ethics,” Brill, last accessed August 21, 2017, 
http://www.brill.com/resources/authors/publishing-journals-brill/publishing-ethics-journals 
58 Ibid 
59 “Publication Ethics and Publication Malpractice Statement,” De Gruyter, last accessed August 21, 2017, 
https://www.degruyter.com/view/j/ejnm.2013.5.issue-4/ejnm-2013-0037/ejnm-2013-0037.xml 
60 Ibid 
Promoting Integrity as an Integral Dimension 
of Excellence in Research 
D 3.5 Handling publishing misconduct | page 43 
 
Elsevier 
 Reviewers61 
Confidentiality.  
Any manuscripts received for review must be treated as confidential documents. 
Reviewers must not share the review or information about the paper with anyone or 
contact the authors directly without permission from the editor. 
Some editors encourage discussion with colleagues or co-reviewing exercises, but 
reviewers should first discuss this with the editor in order to ensure that confidentiality 
is observed and that participants receive suitable credit. 
Unpublished materials disclosed in a submitted manuscript must not be used in a 
reviewer’s own research without the express written consent of the author. Privileged 
information or ideas obtained through peer review must be kept confidential and not 
used for personal advantage. 
 Authors62 
Originality and Acknowledgement of Sources.  
The authors should ensure that they have written entirely original works, and if the 
authors have used the work and/or words of others, that this has been appropriately 
cited or quoted and permission has been obtained where necessary. 
Proper acknowledgment of the work of others must always be given. Authors should cite 
publications that have influenced the reported work and that give the work appropriate 
context within the larger scholarly record. Information obtained privately, as in 
conversation, correspondence, or discussion with third parties, must not be used or 
reported without explicit, written permission from the source. 
Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own 
paper, to copying or paraphrasing substantial parts of another’s paper (without 
attribution), to claiming results from research conducted by others.  Plagiarism in all its 
forms constitutes unethical behaviour and is unacceptable. 
 Plagiarism Quick Guide, Elsevier Publishing Campus 63 
<https://www.publishingcampus.elsevier.com/websites/elsevier_publishingcampus/fil
es/Guides/2017%20ETHICS/2017_ETHICS_PLA02.pdf> 
IOP Publishing 
 Authors64 
Plagiarism 
Submitted articles must be the authors’ own work. Plagiarism constitutes unethical 
scientific behaviour and is never acceptable. Plagiarism ranges from the unreferenced 
use of others’ ideas to submission of a complete paper under 'new' authorship. 
Oxford University Press (OUP) 
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 Plagiarism65 
OUP journals evaluate submissions on the understanding that they are the original work 
of the author(s). We expect that references made in a manuscript or article to another 
person’s work or idea will be credited appropriately. Equally we expect authors to gain 
all appropriate permissions prior to publication. Guidelines on when permissions are 
required and how to seek permissions are available here 
[https://academic.oup.com/DocumentLibrary/journals/pdf-Oxford-Journals-
Guidelines-for-Author-Permissions-September-2014.pdf] OUP is a signatory of the STM 
Permissions Guidelines (detailed here [http://www.stm-assoc.org/permissions-
guidelines/]), which may lower any permissions fees. 
Re-use of text, data, figures, or images without appropriate acknowledgment or 
permission is considered plagiarism, as is the paraphrasing of text, concepts, and ideas. 
All allegations of plagiarism are investigated thoroughly and in accordance with COPE 
guidelines detailed here 
[http://publicationethics.org/files/u7140/plagiarism%20A.pdf]. Many journals now 
systematically run submitted papers through plagiarism-detection software to identify 
possible cases. Journals will typically stipulate how they employ such software - whether 
systematically or selectively - in their submission guidelines. 
Palgrave Macmillan 
 Authors66 
(Should) Ensure that all researched work submitted is original, fully referenced and that 
all authors are represented accurately. The submission must be exclusive and not under 
consideration elsewhere. 
(Should) Expect the editor to scan submissions using plagiarism detection software at 
iThenticate to check a paper's originality before sending out for review. 
 Palgrave Macmillan67 
(Will) Use plagiarism detection software when necessary for any submission to any 
journal at any stage of the submissions and publication process. 
(Will) Investigate thoroughly any suggestion of ethical misconduct detected during any 
stage of the submissions process. This can include, but is not restricted to, the following: 
plagiarism, redundant publication, fabrication or misuse of data and authorial disputes. 
When necessary, request proof of originality/accuracy from the corresponding author of 
any work submitted to any of our journals. 
Public Library of Science (PLOS) 
 Plagiarism68 
Plagiarism is not acceptable in PLOS submissions. Plagiarized content will not be 
considered for publication. If plagiarism is identified, we will follow COPE guidelines 
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[http://publicationethics.org/files/u2/02A_Plagiarism_Submitted.pdf]. 
Plagiarism includes, but is not limited to: 
o Directly copying text from other sources without attribution 
o Copying ideas, images, or data from other sources without attribution 
o Reusing text from your own previous publications without attribution or 
agreement of the editor (read the COPE guidelines on text recycling 
[http://publicationethics.org/files/BioMed%20Central_text_recycling_editorial_g
uidelines.pdf]) 
 Exception: Reusing text from the Methods section in the author’s 
previous publications, with attribution to the source, is acceptable. 
o Using an idea from another source with slightly modified language without 
attribution 
PLOS uses Crossref Similarity Check (powered by iThenticate) 
[http://www.crossref.org/crosscheck/index.html] to screen submitted content for 
originality. Each journal screens a proportion of manuscripts. We will do a follow-up 
investigation if the software raises any concerns. 
If plagiarism is detected during the peer review process, the manuscript may be rejected. 
If plagiarism is detected after publication, we may issue a correction or retract the paper, 
as appropriate. We reserve the right to inform authors' institutions about plagiarism 
detected either before or after publication.  
We expect that editors and reviewers will be vigilant in their evaluation of PLOS 
submissions and will notify the journal about any plagiarism identified. 
 Confidentiality69 
(...) We expect that editors and reviewers will not make use of any material or take 
advantage of any information they gain through the peer review process. 
We will follow up on any and all breaches of confidentiality. If there are any concerns 
about misconduct during the review process, we will follow COPE guidelines 
[http://publicationethics.org/resources/guidelines] in investigating them. 
Redalyc 
 Nothing on the subject 
Rockefeller University Press (RUP) 
 Data integrity and plagiarism70 
All accepted manuscripts will go through a plagiarism and image screening check prior 
to publication. We use Crossref Similarity Check 
[http://www.crossref.org/crosscheck/index.html] to detect for textual similarity with 
other publications, including instances of self-plagiarism. 
Images should be minimally processed and accurately reflect the original data. We 
understand that image processing may be necessary and is appropriate in most 
instances. Our screening process examines the following: whether any specific feature 
within an image has been enhanced, obscured, moved, removed, or introduced; whether 
dividing lines are added between juxtaposed images taken from different parts of the 
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same gel or from different gels, fields, or exposures; whether adjustments of brightness, 
contrast, or color balance have been applied to the entire image and that adjustments do 
not enhance, erase, or misrepresent any information present in the original, including 
the background. We also look for duplicated images within the manuscript; any reuse of 
images, including control data, across multiple figures should be explicitly stated and 
justified in the legend. Nonlinear adjustments (e.g., changes to gamma settings) must be 
disclosed in the figure legend or Materials and methods section. 
If figure resolution or quality is insufficient for proper image screening, we will request 
the original data. Failure to locate original data upon request during the editorial or 
production process will cause delays with your manuscript. In the event that 
inappropriate image processing is identified prior to publication, our editors will contact 
the authors to discuss further. In most instances, we can resolve the issue and move 
forward with publication. In more serious cases where inappropriate image processing 
obscures or changes the conclusions of the manuscript, we may be forced to revoke 
acceptance. 
We investigate all instances of alleged scientific misconduct identified in our published 
papers (including, but not limited to, plagiarism, inappropriate data processing, and 
duplicate publication). Depending on the outcome of our investigation, we may publish a 
correction, ask authors to retract their paper, or publish an editorial statement of 
concern. 
In instances where we are considering revoking acceptance, retracting a published 
article, or issuing an editorial statement of concern, we will contact the corresponding 
author’s institution during the course of our investigation. As Committee on Publication 
Ethics (COPE) members, we abide by COPE guidelines in managing investigations of 
possible misconduct. 
Springer 
o Authors71 
No data, text, or theories by others are presented as if they were the author’s own 
(‘plagiarism’). Proper acknowledgements to other works must be given (this includes 
material that is closely copied (near verbatim), summarized and/or paraphrased), 
quotation marks are used for verbatim copying of material, and permissions are secured 
for material that is copyrighted.  
Important note: the journal may use software to screen for plagiarism. 
o Editors72 
Appropiation 
What to do if you suspect a reviewer has appropriated an author’s idea or data 
[http://publicationethics.org/files/u2/07_Reviewer_misconduct.pdf] 
 
Duplication of text and/or figures (plagiarism) 
Plagiarism  occurs  when  someone  presents  the  work  of  others  (data,  text,  or 
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theories)  as  if  it  were  his/her  own  without proper acknowledgment. There are 
different degrees of plagiarism.  
The   severity   is   dependent   on   various   factors:   extent   of   copied   material,   
originality   of   copied   material, position/context/type of material and 
referencing/attribution of the material used. 
Every  case  is  different  and  therefore  decisions  will  vary  per  case.  Ask  yourself  the  
following  question:  Does  it concern  an  honest  mistake  or  is  there  an  intentional  
deviation  from  the  scientific  norm?  Please  note  there  are many grey areas between 
honest, questionable and fraudulent practices. 
Whilst reviewing the case consider the following factors: 
o Author seniority.  Junior authors may be asked to paraphrase the copied text if it 
is believed that they are  genuinely not aware that copying phrases is 
inappropriate. It is expected that a senior author should know better 
o Cultural background could be an indication for potentially different behaviors 
concerning the amount of copying which could be seen as plagiarism 
The following listing is designed to make you aware of the various possibilities 
concerning plagiarism:  
o Verbatim copying of another’s work and submitting it as one’s own. 
o Verbatim copying of significant portions of text from a single source. 
o Mixing verbatim copied material from multiple sources (“patchwork copying”). 
This could range from 1 or 2 paragraphs to significant portions consisting of 
several paragraphs. 
o Changing key words and phrases but retaining the essential content of the source 
as a framework. 
o Rephrasing of the text’s original wording and/or structure and submitting it as 
one’s own. 
o Mixing slightly rephrased material from multiple sources and presenting what 
has been published already as new. 
o The work is cited, but the cited portions are not clearly identified. This can be 
combined with copied parts of text without citation.  
However for review papers the above is not directly applicable. Review papers are 
expected to give a summary of existing literature. Authors should use their own words  
with exception of properly quoted and/or cited texts and the work should include a new 
interpretation. 
Recommended action by COPE for Journal Editors: 
o Suspected plagiarism in a submitted manuscript 
[http://publicationethics.org/files/u2/02A_Plagiarism_Submitted.pdf] 
o Suspected plagiarism in a published article 
[http://publicationethics.org/files/u2/02B_Plagiarism_Published.pdf] 
For  more  information  on  this  topic; see Avoiding  plagiarism,  self-plagiarism,  and  
other  questionable  writing practices:  A  guide  to  ethical  writing 
[http://ori.hhs.gov/avoiding-plagiarism-self-plagiarism-and-other-questionable-
writing-practices-guide-ethical-writing] by  M.  Roig  (guidelines  developed  with  
support  from  The  Office  of  Research Integrity) and Text Recycling Guidelines 
[http://publicationethics.org/text-recycling-guidelines] from COPE. 
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Ubiquity Press 
 Anti-plagiarism Checking73 
A combination of pre-screening and open access is the best possible defence against 
plagiarism. All journal articles and book manuscripts submitted to Ubiquity Press are 
automatically screened for plagiarism by the Similarity Check system from Crossref. This 
system compares incoming submissions to a large database of academic content, and 
alerts editors to any possible issues. 
Wiley 
 Plagiarism74 
A discussion of plagiarism is provided by the US Office of Research Integrity in its policy 
on plagiarism [http://ori.hhs.gov/ori-policy-plagiarism]. Included in this discussion is 
the general working definition:  
“ORI considers plagiarism to include both the theft or misappropriation of 
intellectual property and the substantial unattributed textual copying of 
another’s work. It does not include authorship or credit disputes.”  
Editors can help educate about and prevent plagiarism (as well as redundant or 
duplicate publication) by screening submitted manuscripts. Journals should explain in 
their instructions to authors how submitted manuscripts are screened for duplicated text 
and possible plagiarism. CrossCheck is one of the screening services available for this 
purpose. Journals may consider the following text, adapted from the CrossCheck website: 
“CrossCheck is a multi-publisher initiative to screen published and submitted 
content for originality. This journal uses the iThenticate software to detect 
instances of overlapping and similar text in submitted manuscripts. The 
‘CrossCheck Deposited’ or ‘CrossCheck Depositor’ logos indicate that this journal 
has committed to actively combating plagiarism. To find out more about 
CrossCheck visit http://www.crossref.org/crosscheck.html.” 
The sample text is here 
[http://www.crossref.org/06members/46guidelines.html#Sample_Copy_CrossCheck]. 
 Sanctions [for duplicate, redundant, and plagiarism]75 
Wiley has published advice about sanctions 
[http://authorservices.wiley.com/bauthor/faqs_copyright.asp#1.25] in which we refer 
to the COPE guidelines. Journals may, for example, publish a retraction, may inform the 
author’s institution, and may refuse for a time to consider future work from the authors.  
o Before considering sanctions editors must consult with their publisher, 
particularly for legal advice, and also with the journal owner (for example, a 
scholarly society). 
o Sanctions should be applied consistently and only after careful consideration. 
Before imposing sanctions, journals should formally define the conditions in which they 
will apply (and remove) sanctions, and the processes they will use to do this. 
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Duplicate and redundant publication 
Brill 
 Authors76 
Multiple manuscript submission 
Authors should not submit manuscripts with essentially the same content to more than 
one publication [A journal, book series, edited volume or reference work.], except if 
expressly communicated and agreed. Otherwise submitting the same manuscript to 
more than one publication simultaneously is considered to be unethical, unacceptable, 
publishing behavior. 
De Gruyter 
 Authors77 
Multiple, redundant or concurrent publication  
An author should not in general publish manuscripts describing essentially the same 
research in more than one journal or primary publication. Parallel submission of the 
same manuscript to more than one journal constitutes unethical publishing behavior and 
is unacceptable. 
Elsevier 
 Authors (Publishing Ethics) 78 
Multiple, Redundant or Concurrent Publication.  
An author should not in general publish manuscripts describing essentially the same 
research in more than one journal of primary publication. Submitting the same 
manuscript to more than one journal concurrently constitutes unethical behaviour and is 
unacceptable. 
In general, an author should not submit for consideration in another journal a paper that 
has been published previously, except in the form of an abstract or as part of a published 
lecture or academic thesis or as an electronic preprint. 
Publication of some kinds of articles (e.g. clinical guidelines, translations) in more than 
one journal is sometimes justifiable, provided certain conditions are met. The authors 
and editors of the journals concerned must agree to the secondary publication, which 
must reflect the same data and interpretation of the primary document. The primary 
reference must be cited in the secondary publication. Further detail on acceptable forms 
of secondary publication can be found from the ICMJE [ICMJE Uniform requirements for 
manuscripts submitted to biomedical journals http://www.icmje.org]. 
 Authors (Journal) 79 
Multiple, redundant or concurrent publication 
An author should not in general publish manuscripts describing essentially the same 
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research in more than one journal or primary publication. Elsevier does not view the 
following uses of a work as prior publication: publication in the form of an abstract; 
publication as an academic thesis; publication as an electronic preprint. Information on 
prior publication is included within each Elsevier journal’s Guide for Authors. Note: Cell 
Press, The Lancet, and some society-owned titles have different policies on prior 
publication. Information on these is available on the journal homepage. 
 Salami slicing Quick Guide, Elsevier Publishing Campus 80 
<https://www.publishingcampus.elsevier.com/websites/elsevier_publishingcampus/fil
es/Guides/2017%20ETHICS/2017_ETHICS_SS02.pdf> 
 Duplicate submissions Quick Guide, Elsevier Publishing Campus81  
<https://www.publishingcampus.elsevier.com/websites/elsevier_publishingcampus/fil
es/Guides/2017%20ETHICS/2017_ETHICS_SS02.pdf> 
IOP Publishing 
 Authors82 
Duplicate publication/self-plagiarism 
Duplicate publication (sometimes called 'self-plagiarism') is the production of multiple 
papers with the same, or essentially the same, content by the same authors and is viewed 
as unacceptable. Submitted research articles must be novel and original. 
In the case of articles that expand upon previously published conference proceedings, or 
conference write-ups that discuss work already published in an earlier paper, some 
limited exceptions to this rule may apply. However, in these cases authors should consult 
with the journal staff before submission. In all instances, articles must clearly cite their 
sources and present some new contribution to the published literature otherwise such 
articles will be rejected. 
Multiple publications arising from a single research project should be clearly identified 
as such and the primary publication should be referenced. Translations and adaptations 
for different audiences should be clearly identified as such, should acknowledge the 
original source, and should respect relevant copyright conventions and permission 
requirements. If in doubt, authors should seek permission from the original publisher 
before republishing any work. 
Parallel submission 
It is also unethical to submit the same, or essentially the same, article to a second 
primary research journal whilst it remains under active consideration by another. 
To aid us in detecting any submissions that do not meet the above requirements, we 
regularly use plagiarism-detection software to screen articles. 
Oxford University Press (OUP) 
 Redundant publication (dual submission or publication)83 
OUP-published journals evaluate submissions on the understanding that they have not 
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been previously published in or simultaneously submitted to another journal. We 
encourage all OUP-published journals to investigate allegations of redundant publication 
thoroughly and in accordance with COPE guidelines detailed here 
[http://publicationethics.org/files/u7140/redundant%20publication%20A.pdf]. We 
also encourage editors and journal administrators to keep a clear record of all 
communications between authors, editors, and peer reviewers regarding the 
submissions they handle. These records are carefully stored and may be used to facilitate 
investigations into possible cases of misconduct. Where necessary we will contact 
and/or co-operate with other publishers and journals to identify cases of redundant 
publication. 
Palgrave Macmillan 
 Authors84 
(Should) Ensure that all researched work submitted is original, fully referenced and that 
all authors are represented accurately. The submission must be exclusive and not under 
consideration elsewhere. 
 Pallgrave Macmillan85 
(Will) Investigate thoroughly any suggestion of ethical misconduct detected during any 
stage of the submissions process. This can include, but is not restricted to, the following: 
plagiarism, redundant publication, fabrication or misuse of data and authorial disputes. 
Public Library of Science (PLOS) 
 Author requirements86 
Upon submission of a manuscript, authors must indicate whether there are any related 
manuscripts under consideration or published elsewhere. If related work has been 
submitted or published elsewhere, authors must include a copy of it with their 
submission and describe its relation to the submitted work. 
Prior publication of research as a thesis, presentation at medical or scientific 
conferences, or posting on preprint servers will not preclude consideration of your 
manuscript. 
PLOS supports the public disclosure of all clinical trial results, as mandated, for example, 
by the 2007 FDA Amendments Act. Prior disclosure of results on a clinical trial registry 
site will not affect consideration. 
 Editor and reviewer requirements87 
Reviewers and editors should evaluate any related content and notify the journal of 
overlap. Editors and reviewers should alert the journal if they identify duplicate 
submissions or publications during the review process. 
 Policy enforcement88 
If related content is found to be too similar to the PLOS submission, or if a duplicate 
submission is discovered, we will reject the manuscript. 
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Duplicate content discovered after publication will be addressed depending on the 
degree of overlap. The journal may issue a correction or a retraction as appropriate. 
Redalyc 
 Nothing on the subject 
Rockefeller University Press (RUP) 
 Duplicate publication89 
When submitting a manuscript, the authors should affirm that no similar manuscript 
(including book chapters) is or will be under consideration for publication elsewhere 
(other than as an abstract that is less than 400 words in length and contains no figures). 
Any unpublished articles that are related to or could be perceived to overlap with the 
submitted manuscript must be included for evaluation by the editors and reviewers. 
Doctoral theses or dissertations are not regarded as prior publications. 
Springer 
o Authors90 
The manuscript has not been submitted to more than one journal for simultaneous 
consideration.  
The manuscript has not been published previously (partly or in full), unless the new 
work concerns an expansion of previous work (please provide transparency on the re-
use of material to avoid the hint of text-recycling (‘self-plagiarism’)). 
A single study is not split up into several parts to increase the quantity of submissions 
and submitted to various journals or to one journal over time (e.g.  ‘salami-publishing’). 
o Editors91 
Duplicate submission/publication and redundant publication 
Duplicate  submission/publication:  This  refers  to  the  practice  of  submitting  the  
same  study to two journals or publishing more or less the   same   study   in   two   
journals.   These   submissions/publications can be nearly simultaneous or years later. 
Redundant publication (also described as ‘salami publishing’): this refers to the situation 
that one study is split into several  parts  and  submitted  to  two  or  more  journals.    Or  
the findings  have  previously  been  published  elsewhere without  proper  cross-
referencing,  permission  or  justification.  
“Self-plagiarism” is considered a form of redundant publication. It concerns  recycling  or  
borrowing  content  from  previous  work  without  citation.  This  practice  is widespread  
and  might  be  unintentional. Transparency  by  the  author  on  the  use  of  previously  
published  work usually provides the necessary information to make an assessment on 
whether it is deliberate or unintentional. 
Note! Translations  of  articles  without  proper permission  or  notification  and  
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resubmission  of  previously  published Open Access articles are considered duplications. 
Recommended action by COPE for Journal Editors: 
o Suspected redundant (duplicate) publication in a submitted manuscript 
[http://publicationethics.org/files/u2/01A_Redundant_Submitted.pdf] 
o Suspected redundant (duplicate) publication in a published article 
[http://publicationethics.org/files/u2/01B_Redundant_Published.pdf] 
Ubiquity Press 
 Nothing on the subject under the general policies 
Wiley 
 Duplicate and redundant publication92 
The Council of Science Editors incorporates a definition of duplicate or redundant 
publication into its White Paper on Promoting Integrity in Scientific Journal Publications 
[http://www.councilscienceeditors.org/files/public/entire_whitepaper.pdf]: “[A]uthors 
must avoid duplicate publication, which is reproducing verbatim content from their 
other publications.” 
Wiley has also published information about duplicate publication 
[http://authorservices.wiley.com/bauthor/faqs_copyright.asp]. 
Journals should establish processes to help them avoid duplicate and redundant 
publication. The Copyright Transfer Agreement, Exclusive License Agreement or the 
Open Access Agreement, one of which must be submitted before publication in any Wiley 
journal, requires signature from the corresponding author to warrant that the article is 
an original work, has not been published before, and is not being considered for 
publication elsewhere in its final form.  
o Journals should remind authors that duplicate publication is not acceptable. 
o Journals should require that any previously published results, including 
numerical information and figures or images, are labeled to make it clear where 
they were previously reported.  
o Papers, particularly medical research papers, that present new analyses of 
results that have already been published (for example, subgroup analyses) 
should identify the primary data source, and include a full reference to the 
related primary publications.   
Journals from different disciplines vary in their approach to pre-print servers. Many 
biomedical journals would consider posting an article to a pre-print server to render any 
subsequent journal publication redundant. Thus an article submitted for consideration 
after having been posted to a pre-print server would be rejected. However, many 
researchers working in physics, mathematics, computer science, quantitative biology, 
quantitative finance and statistics post their articles to arXiv before submitting an article 
successfully to a journal for peer review and publication. Journals should establish a 
policy about pre-print servers and declare this in their instructions for authors. Any 
previous publication should be disclosed in the paper. 
The following types of “prior publication” do not present cause for concerns about 
duplicate or redundant publication:  
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o Abstracts and posters presented during sessions at conferences. 
o Results presented at meetings (for example, to inform investigators or 
participants about findings). 
o Results in databases and clinical trials registries (data without interpretation, 
discussion, context or conclusions in the form of tables and text to describe 
data/information). 
o Dissertations and theses in university archives. 
If a paper is published and later found to be redundant, the editor should refer to the 
COPE Flowcharts [http://publicationethics.org/resources/flowcharts]and should 
consider working with their publisher to retract the duplicate paper.  
Text recycling  
COPE hosted a discussion about text recycling [http://publicationethics.org/text-
recycling-guidelines]. The US Office of Research Integrity has also published on this topic 
in its document “Avoiding plagiarism, self-plagiarism, and other questionable writing 
practices: A guide to ethical writing.[http://ori.hhs.gov/plagiarism-13]”  
Journals may find it useful to establish a policy about how much, if any, and under what 
circumstances they consider it acceptable to recycle text and results between articles.  
This may be important, for example, for authors who wish to communicate results from a 
research project to multiple audiences. In this instance, full or partial results might be 
recycled for legitimate reasons, although the discussion and conclusions would be 
different. Duplicate submission 
Journals should consider how they might detect concurrent or multiple submissions. For 
example, in cases where journals are part of an editorial group or portfolio with access to 
internal information for the whole journal family, detection aids or mechanisms should 
be put in place for editors to use as part of their editorial office system.  
If concurrent or multiple submissions are detected, the editor should work with their 
publisher and refer to the COPE flowchart 
[http://publicationethics.org/resources/flowcharts] on redundant publication in a 
submitted manuscript. 
Duplicate information published in translations 
Journals may choose to publish materials that have been accurately translated from an 
original publication in a different language. Journals that translate and publish material 
that has been published elsewhere should ensure that they have appropriate permission. 
They should indicate clearly that the material has been translated and republished, and 
should identify the original source of the material.  
 Sanctions [for duplicate, redundant, and plagiarism]93 
Wiley has published advice about sanctions 
[http://authorservices.wiley.com/bauthor/faqs_copyright.asp#1.25] in which we refer 
to the COPE guidelines. Journals may, for example, publish a retraction, may inform the 
author’s institution, and may refuse for a time to consider future work from the authors.  
o Before considering sanctions editors must consult with their publisher, 
particularly for legal advice, and also with the journal owner (for example, a 
scholarly society). 
o Sanctions should be applied consistently and only after careful consideration. 
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o Before imposing sanctions, journals should formally define the conditions in 
which they will apply (and remove) sanctions, and the processes they will use to 
do this. 
 
Compliance with ethical standards 
Brill 
 Nothing on the subject 
De Gruyter 
 Authors94 
Hazards and human or animal subjects If the work involves chemicals, procedures or 
equipment that have any unusual hazards inherent in their use, the authors must clearly 
identify these in the manuscript. 
Elsevier 
 Patient consent (as a general policy)95 
Appropriate consents, permissions and releases must be obtained where authors wish to 
include case details or other personal information or images of patients and any other 
individuals in an Elsevier publication 
o Requirement for consent 
Appropriate consents, permissions and releases must be obtained where authors 
wish to include case details or other personal information or images of patients 
and any other individuals in an Elsevier publication in order to comply with all 
applicable laws and regulations concerning the privacy and/or security of 
personal information, including, but not limited to, the Health Insurance 
Portability and Accountability Act of 1996 ("HIPAA") and other U.S. federal and 
state laws relating to privacy and security of personally identifiable information, 
the European Union Directive 95/46/EC and member state implementing 
directives, Canada's Personal Information Protection and Electronic Documents 
Act, India's Information Technology Act and related Privacy Rules, (together 
"Data Protection and Privacy Laws"). 
It is the responsibility of the author to ensure that: 
 Each individual, or the individual's legal guardian or other person with 
legal authority to act on the individual's behalf who appears in any video, 
recording,photograph, image, illustration or case report (or in any other 
identifiable form) is made aware in advance of the fact that such 
photographs are being taken or such video, recording, photograph, 
image, illustration or report is being made, and of all the purposes for 
which they might be used, including disclosure to Elsevier and use by 
Elsevier or its licensees in any work or product. That individual, legal 
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guardian or person with legal authority must give his/her explicit written 
consent. If such consent is made subject to any conditions (for example, 
adopting measures to prevent personal identification of the person 
concerned), Elsevier must be made aware in writing of all such 
conditions. Written consents must be retained by the author and copies 
of the consents or evidence that such consents have been obtained must 
be provided to Elsevier on request 
 The form of written consent complies with each requirement of all 
applicable Data Protection and Privacy Laws. Particular care should be 
taken with obtaining consent where children are concerned (in particular 
where a child has special needs or learning disabilities), where an 
individual's head or face appears, or where reference is made to an 
individual's name or other personal details. 
 In the case of a child, if parents or guardians disagree on the use of the 
images of that child, then consent should be deemed not to have been 
given and those images should not be used. It is also important to ensure 
that only images of children in suitable dress are used to reduce the risk 
of images being used inappropriately. 
 Even if consent has been obtained, care must be taken to ensure that the 
portrayal and captioning of the individual concerned are respectful and 
could not be seen as denigrating that individual. 
o Special considerations 
 Patients' and research subjects' names, initials, hospital or social security 
numbers, dates of birth or other personal or identifying information 
should not be used. 
 Images of patients or research subjects should not be used unless the 
information is essential for scientific purposes and explicit permission 
has been given as part of the consent. Even where consent has been 
given, identifying details should be omitted if they are not essential. 
 If identifying characteristics are altered to protect anonymity, authors 
should provide assurances that such alterations do not distort scientific 
meaning. 
o Non-identifiable images 
 Formal consents are not required for the use of entirely anonymised 
images from which the individual cannot be identified- for example, 
xrays, ultrasound images, pathology slides or laparoscopic images, 
provided that these do not contain any identifying marks and are not 
accompanied by text that might identify the individual concerned. 
  If consent has not been obtained, it is generally not sufficient to 
anonymise a photograph simply by using eye bars or blurring the face of 
the individual concerned. 
 Authors96 
Hazards and Human or Animal Subjects.  
If the work involves chemicals, procedures or equipment that have any unusual hazards 
inherent in their use, the author must clearly identify these in the manuscript. 
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If the work involves the use of animal or human subjects, the author should ensure that 
the manuscript contains a statement that all procedures were performed in compliance 
with relevant laws and institutional guidelines and that the appropriate institutional 
committee(s) have approved them. Authors should include a statement in the 
manuscript that informed consent was obtained for experimentation with human 
subjects.  The privacy rights of human subjects must always be observed. 
For human subjects, the author should ensure that the work described has been carried 
out in accordance with The Code of Ethics of the World Medical Association (Declaration 
of Helsinki) for experiments involving humans [World Medical Association (WMA) 
Helsinki Declaration for Medical Research in Human Subject 
<https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-
for-medical-research-involving-human-subjects>].  All animal experiments should 
comply with the ARRIVE guidelines [Animal Research: Reporting of In Vivo Experiments 
(ARRIVE) Guidelines <https://www.nc3rs.org.uk/arrive-guidelines>] and should be 
carried out in accordance with the U.K. Animals (Scientific Procedures) Act 1986 and 
associated guidelines [the U.K. Animals (Scientific Procedures) Act 1986 
<https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/308
593/ConsolidatedASPA1Jan2013.pdf>], or  EU Directive 2010/63/EU on the protection 
of animals used for scientific purposes [EU Directive 2010/63/EU for animal 
experiments 
<http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm>], or the 
U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and, as 
applicable, the Animal Welfare Act [U.S. Public Health Service Policy on Humane Care 
and Use of Laboratory Animals 
<https://grants.nih.gov/grants/olaw/references/phspolicylabanimals.pdf>]. 
Appropriate consents, permissions and releases must be obtained where an author 
wishes to include case details or other personal information or images of patients and 
any other individuals in an Elsevier publication. Written consents must be retained by 
the author and copies of the consents or evidence that such consents have been obtained 
must be provided to Elsevier on request [Elsevier policy on patient consent: 
<ahttps://www.elsevier.com/about/company-information/policies/patient-consent>]. 
Clinical Trial Transparency.  
Elsevier supports clinical trial transparency.  For relevant journals, authors are expected 
to conform to industry best standards in in clinical trial registration and presentation, for 
example the CONSORT guidelines, as further set out in the policies of the relevant journal 
[ICMJE Uniform requirements for manuscripts submitted to biomedical journals 
<http://www.icmje.org/>, CONSORT standards for randomized trials 
<http://www.consort-statement.org>]. 
IOP Publishing 
 Investigations involving live subjects97 
All investigations involving humans must be conducted in accordance with the principles 
embodied in the Declaration of Helsinki 
[http://www.wma.net/en/30publications/10policies/b3/index.html] and in accordance 
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with local statutory requirements. Researchers should not generally publish or share 
identifiable individual data collected in the course of research without specific consent 
from the individual (or their representative). Articles relying on clinical trials should 
quote the trial registration number at the end of the abstract. IOP also encourages the 
registration of such studies in a public trials registry prior to publication of the results in 
the journal. All investigations involving animal experimentation must be conducted in 
accordance with the Guiding Principles for Research Involving Animals and Human 
Beings [http://www.the-aps.org/mm/Publications/Info-For-Authors/Animal-and-
Human-Research] as adopted by the American Physiological Society, and with local 
statutory requirements. 
Oxford University Press (OUP) 
 Promoting ethical research98 
As a department of Oxford University, it is part of OUP’s mission to promote the highest 
standards of research through its publishing activities. Ensuring that the research we 
publish is conducted in a fair and ethical manner is integral to this. We publish across 
multiple research areas, many of which have their own standards and methods of 
governing research practice. 
Wherever appropriate, we expect published research based on human subjects to 
provide the name of the local ethics committee that approved the study (or confirmation 
that such approval is not needed) and/or to state how the study conforms to recognised 
standards (e.g. declaration of Helsinki or US Federal Policy for the Protection of Human 
Subjects). OUP encourages journals and handling editors to return any manuscripts 
describing studies not meeting acceptable criteria. 
The following list details OUP’s approach to the most common areas of research 
integrity. 
a. Patient confidentiality 
Journals publishing studies using human subjects should ensure that a patient's 
right to privacy has not been infringed without prior consent. We encourage 
journals to follow the ICMJE [http://www.icmje.org/index.html#privacy] 
guidelines for reporting on human subjects. For publication of material that 
contains detailed patient information about a living individual, it is compulsory 
for a signed patient consent to be obtained. Any identifier that might reveal a 
patient’s identity must be removed (i.e., x-rays, MRIs, charts, photographs, etc.). 
Written informed consent is required from any potentially identifiable patient or 
legal representative, and should be presented in either the Methods section or 
the Acknowledgements. 
b. Animal experimentation 
Where animals are used in research we expect them to have been treated in a 
humane manner and in line with the ARRIVE [http://www.nc3rs.org.uk/arrive-
guidelines] guidelines. The International Council for Laboratory Animal Science 
has published guidelines specifically for editors and Reviewers on how to handle 
submissions involving animal research. OUP supports these guidelines and, 
wherever possible, encourages editors and society partners to adopt them. 
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Authors may be required to provide evidence that they obtained ethical and /or 
legal approval prior to conducting the research. 
c. Registering clinical trials 
All clinical trials should be registered prospectively in publically accessible 
databases (e.g. www.clinicaltrials.gov and www.clinicaltrialsregister.eu) and 
manuscripts should include registration numbers and the name of the register. 
Some journals may require clinical trials to be reported according to CONSORT 
[http://www.consort-statement.org/)] guidelines. 
Falsification and fabrication 
Submitted papers found to include false or fabricated data prior to publication 
will be returned to the author immediately with a request for an explanation. If 
no explanation is received or if the explanation provided is considered 
unsatisfactory, the journal will notify the authors’ institution, local ethical 
committee, or superior. The journal may also refuse to accept further 
submissions from the author for a defined period. 
Examples of data falsification or fabrication include: image manipulation; 
cropping of gels/images to change context; omission of selected data; or making-
up data sets. Some journals employ image manipulation software to detect 
evidence of falsification in submitted manuscripts. OUP recognises that 
falsification is not always deliberate and will encourage its journals and 
publishing partners to consider each case on its terms. 
Palgrave Macmillan 
 Nothing on the subject 
Public Library of Science (PLOS) 
 Best Practices in Research Reporting99 
All research submitted to PLOS journals must be reported according to internationally 
accepted standards for the study type, with ethics oversight obtained where appropriate. 
 Animal Research100 
Research involving regulated animals must meet internationally accepted ethics 
standards for the study type, including but not limited to obtaining study-specific 
approval by the appropriate ethics committee, securing appropriate permits to conduct 
the research, and providing required details for studies involving non-human primates. 
 Human Subjects Research101 
Research involving human participants must meet internationally accepted ethics 
standards for the study type, including but not limited to obtaining study-specific 
approval by the appropriate ethics committee, taking steps to protect participant 
privacy, obtaining informed consent and providing clinical trial documentation. 
Redalyc 
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 Nothing on the subject 
 
Rockefeller University Press (RUP) 
 Animal and human studies102 
All animal and human studies must be conducted in compliance with relevant local 
guidelines, such as the US Department of Health and Human Services Guide for the Care 
and Use of Laboratory Animals [http://www.nap.edu/openbook.php?record_id=5140] 
or MRC guidelines [https://www.mrc.ac.uk/funding/guidance-for-applicants/], and 
must be approved by the authors' Institutional Review Board(s). A statement to this 
effect with the name of the approving IRB(s) must be included in the Materials and 
methods section. All investigations with human subjects must be conducted according to 
the principles expressed in the Helsinki Declaration 
[http://www.wma.net/en/20activities/10ethics/10helsinki/index.html] and must 
include a statement that informed consent was obtained from all subjects. We strongly 
encourage authors to use the appropriate Reporting Guidelines 
[http://jcb.rupress.org/submission-guidelines#reporting-guidelines] for their study 
type. 
Springer 
 Compliance with ethical standards103 
To ensure objectivity and transparency in research and to ensure that accepted 
principles of ethical and professional conduct have been followed, authors should 
include information regarding sources of funding, potential conflicts of interest (financial 
or non-financial), informed consent if the research involved human participants, and a 
statement on welfare of animals if the research involved animals. 
Authors should include the following statements (if applicable) in a separate section 
entitled “Compliance with Ethical Standards” before the References when submitting a 
paper: 
Disclosure of potential conflicts of interest 
Research involving Human Participants and/or Animal 
Informed consent 
Please note that standards could vary slightly per journal dependent on their peer 
review policies (i.e. double blind peer review) as well as per journal subject discipline. 
Before submitting your article check the Instructions for Authors carefully. 
The corresponding author should be prepared to collect documentation of compliance 
with ethical standards and send if requested during peer review or after publication. 
The Editors reserve the right to reject manuscripts that do not comply with the above-
mentioned guidelines. The author will be held responsible for false statements or failure 
to fulfill the above-mentioned guidelines. 
                                                          
102 “Editorial Policies,” Rockefeller University Press, last accessed August 23, 2017, 
http://jgp.rupress.org/editorial-policies 
103 “Publishing ethics,” Springer, last accessed August 23, 2017, https://www.springer.com/gp/authors-
editors/journal-author/journal-author-helpdesk/publishing-ethics/14214 
Promoting Integrity as an Integral Dimension 
of Excellence in Research 
D 3.5 Handling publishing misconduct | page 61 
 
Ubiquity Press 
 Nothing on the subject under the general policies 
 
Wiley 
 Human rights, privacy, and confidentiality104 
For manuscripts reporting medical studies involving human participants, it is suggested 
that journals require authors to provide a statement identifying the ethics committee 
that approved the study, and that the study conforms to recognized standards, for 
example: 
o Declaration of Helsinki 
[http://www.wma.net/en/30publications/10policies/b3/] 
o US Federal Policy for the Protection of Human Subjects 
[http://www.hhs.gov/ohrp/humansubjects/commonrule/]  
o European Medicines Agency Guidelines for Good Clinical Practice 
[http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guidelin
e/2009/09/WC500002874.pdf] 
These standards encourage authors to conduct studies in a way that ensures adequate 
steps have been taken to minimize harm to participants, to avoid coercion or 
exploitation, to protect confidentiality, and to minimize the risk of physical and 
psychological harm. 
Across the scholarly disciplines there are variations in practice around privacy and 
confidentiality, relative to the risks of participation and the reasonable expectations of 
participants. 
In the biomedical sciences, editors should consider only publishing information and 
images from individual participants where the authors have obtained the individual's 
free prior informed consent. The International Committee of Medical Journal Editors 
[http://www.icmje.org/icmje-recommendations.pdf] guidance says: 
"Non-essential identifying details should be omitted. Informed consent should be 
obtained if there is any doubt that anonymity can be maintained. For example, 
masking the eye region in photographs of patients is inadequate protection of 
anonymity." 
The best policy is for journals to require that authors confirm whether explicit written 
consent to publish has been received from any people described (for example, in case 
reports), shown in still or moving images, or whose voices are recorded. In the case of 
technical images (for example, radiographs or micrographs), editors should also ensure 
that all information that could identify the subject has been removed from the image. For 
voices or images of any human subject, permission according to applicable national laws 
must be sought from research participants before recording. In many jurisdictions it is a 
requirement that formal copyright clearance is obtained to publish any video or audio 
recordings. When publishing genetic sequences or family genograms editors may need 
consent[http://www.nature.com/news/deal-done-over-hela-cell-line-1.13511]  from 
more than just the index case. The CARE guidelines [http://www.care-statement.org/] 
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are useful for editors who publish case reports. 
In the social sciences and humanities, there are numerous ethical guidelines for 
researchers working with human participants. Social science and humanities researchers 
regularly work with audio and video materials gathered in public places where there is 
no reasonable expectation of privacy. They also use materials derived from broadcast 
sources, as in some political science or cultural studies work, where copyright must be 
addressed but where consent issues do not arise. However, wherever appropriate, social 
scientists are also responsible for protecting the confidentiality of human participants, 
and obtaining informed consent from all participants by openly communicating any and 
all information that is likely to influence their willingness to participate (for example, 
sponsorship, purpose and anticipated outcomes, and possible consequences that 
publication of the research may have for participants). Guidelines include those from the 
American Sociological Association 
[http://www.asanet.org/images/asa/docs/pdf/CodeofEthics.pdf], International Society 
of Ethnobiology [http://ethnobiology.net/docs/ISE%20COE_Eng_rev_24Nov08.pdf], and 
American Anthropological Association 
[http://www.aaanet.org/profdev/ethics/upload/Statement-on-Ethics-Principles-of-
Professional-Responsibility.pdf]. 
For social research data the Association of Social Anthropologists of the UK and the 
Commonwealth suggests in its "Ethical Guidelines for Good Research Practice" 
[http://www.theasa.org/downloads/ASA%20ethics%20guidelines%202011.pdf] that it 
is not always possible or necessary to gain written consent to publish, particularly when 
researchers are working with people with limited literacy or in cultures where formal 
bureaucratic procedures are problematic. However, it remains prudent for journals to 
ask authors to provide evidence that they have obtained informed consent. The 
American Anthropological Association's statement 
[http://www.aaanet.org/profdev/ethics/upload/Statement-on-Ethics-Principles-of-
Professional-Responsibility.pdf] recommends that: 
"Informed consent does not necessarily imply or require a particular written or 
signed form. It is the quality of the consent, not its format, which is relevant." 
Exceptional cases might arise where gaining an individual's free prior informed consent 
is not possible but where publishing an individual's information or image can be 
demonstrated to have a genuine public health interest or to serve an important public 
need. In cases like this, before taking any action editors should seek and follow counsel 
from the journal owner, the publisher, and/or legal professionals. 
 Cultures and heritage105 
US Office for Human Research Protection has a searchable database 
[http://ohrp.cit.nih.gov/search/irbsearch.aspx?styp=bsc] of independent community 
institutional review boards that approve research and publication of culturally sensitive 
materials. More information is provided in "Principles and Procedures: Conducting 
Research in a Maori Context" [https://wintecac-
public.sharepoint.com/postgraduate/files/ResearchMaoriContext_PartA.pdf] from 
Waikato Institute of Technology and "Community IRBs and Research Review Boards: 
Shaping the Future of Community-Engaged Research" 
[http://ccph.memberclicks.net/assets/Documents/FocusAreas/shaping_the_future_of_c
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enr.pdf] from Albert Einstein College of Medicine. 
There is recognition of increasing innovation in the management of joint copyright in 
relation to intercultural research, to enable appropriate legal acknowledgment of 
intellectual property in attribution and acknowledgment. This is presented in the section 
on authorship which follows. 
Editors should consider any sensitivities when publishing images of objects that might 
have cultural significance or cause offence (for example, religious texts or historical 
events). In addition: 
o Editors should be conscious of the ethics surrounding publication of images of 
human remains, and should recognize that human remains are perceived 
differently in different cultures. Images of human remains should not be 
published without consideration of the views of any demonstrated genealogical 
descendants or affiliated cultural communities, if feasible. In cases where 
descendants or affiliated cultural communities cannot be contacted, images of 
human remains should not be published without consultation with and 
permission from the curating institution or relevant stakeholder. For more 
information refer to the British Association of Biological Anthropology and 
Osteoarchaeology Code of Ethics [http://www.babao.org.uk/index/ethics-and-
standards]. 
o Cultural restrictions do exist in some cultures that prevent publication of the 
names of deceased people [http://onlinelibrary.wiley.com/doi/10.1111/j.1440-
172X.2007.00667.x/full]. In Aboriginal Australian culture, this often extends to 
publication of photographs or film footage of deceased persons. Editors are 
encouraged to consider any sensitivities and, if necessary, confer with the author 
about appropriate representation of subjects in published work. 
 Registering clinical trials106 
The World Health Organization 
[http://www.who.int/mediacentre/news/releases/2006/pr25/en/index.html] and 
Declaration of Helsinki [http://www.wma.net/en/30publications/10policies/b3/] both 
suggest that clinical trials should be registered prospectively, before participants are 
enrolled. The International Federation of Pharmaceutical Manufacturers and 
Associations [http://www.ifpma.org/] also requires its members to register trials. 
Legislation varies. For example, the US Food and Drug Administration Amendments Act 
of 2007 does not require registration for Phase 1 studies. 
Medical journals that publish clinical trials should make prospective registration a 
requirement for publication of such trials. Clinical trial registration numbers should be 
included in all papers that report their results. A suitable statement about this in journal 
instructions for authors might read: "We require that clinical trials are prospectively 
registered in a publicly accessible database. Please include the name of the trial register 
and your clinical trial registration number at the end of your abstract. If your trial is not 
registered, or was registered retrospectively, please explain the reasons for this." 
 Animals in research107 
Research involving animals should be conducted with the same rigor as research in 
humans. Journals can encourage authors to implement the 3Rs principles 
[http://www.nc3rs.org.uk/page.asp?id=7]: 
                                                          
106 Ibid 
107 Ibid 
Promoting Integrity as an Integral Dimension 
of Excellence in Research 
D 3.5 Handling publishing misconduct | page 64 
 
"The 3Rs are a widely accepted ethical framework for conducting scientific experiments 
using animals humanely: Replacement - use of non-animal methods; Reduction - 
methods which reduce the number of animals used; Refinement - methods which 
improve animal welfare." 
The International Council for Laboratory Animal Science has published ethical guidelines 
[http://iclas.org/committees/ethics-and-animal-welfare-committee] for editors and 
reviewers. 
Journals should encourage authors to adhere to animal research reporting standards, for 
example the ARRIVE reporting guidelines [http://www.nc3rs.org.uk/page.asp?id=1357], 
which describe the details journals should require from authors regarding: 
o Study design and statistical analysis. 
o Experimental procedures. 
o Experimental animals. 
o Housing and husbandry. 
Journals should ask authors to confirm that ethical and legal approval was obtained prior 
to the start of the study, and state the name of the body giving the approval. Authors 
should also state whether experiments were performed in accordance with relevant 
institutional and national guidelines and regulations. 
o US authors should cite compliance with the US National Research Council's 
"Guide for the Care and Use of Laboratory Animals, 
[http://www.nap.edu/openbook.php?record_id=5140]" the US Public Health 
Service's "Policy on Humane Care and Use of Laboratory Animals, 
[http://grants.nih.gov/grants/olaw/references/phspol.htm]" and "Guide for the 
Care and Use of Laboratory Animals [ http://grants.nih.gov/grants/olaw/Guide-
for-the-Care-and-Use-of-Laboratory-Animals.pdf]." 
o UK authors should conform to UK legislation under the Animals (Scientific 
Procedures) Act 1986 Amendment Regulations (SI 2012/3039) 
[https://www.gov.uk/government/publications/animals-scientific-procedures-
act-1986-amendment-regulations]. 
o European authors outside the UK should conform to Directive 2010/63/EU 
[http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32010L0063:EN:NOT]. 
Editors may ask authors to describe in their articles how discomfort, distress, and pain 
were avoided and minimized, and to confirm that animals did not suffer unnecessarily at 
any stage of an experiment. 
Editors may request that reviewers comment on the standard of experimental reporting, 
experimental design, or any other aspects of the study reported that may cause concern. 
If concerns are raised or clarifications are needed, they may need to request evidence of 
ethical research approval or question authors. 
 Biosecurity108 
Journals should ask authors to inform them at the time of manuscript submission if their 
study has potential for both benevolent and malevolent application. This is often 
referred to as "dual use research." 
Journals should ask these authors to conform to the National Science Advisory Board for 
Biosecurity (NSABB) [http://osp.od.nih.gov/office-biotechnology-
                                                          
108 Ibid 
Promoting Integrity as an Integral Dimension 
of Excellence in Research 
D 3.5 Handling publishing misconduct | page 65 
 
activities/biosecurity/nsabb] guidelines for Dual Use Life Sciences Research. The June 
2007 NSABB 
[http://osp.od.nih.gov/sites/default/files/resources/Framework%20for%20transmittal
%20duplex%209-10-07.pdf] report presents a useful description and discussion of "dual 
use research of concern." 
